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CHAPTER I
Introduction
Description of the Problem
Itch is an irritation of the skin, which can be as distressing as pain. Itch is as familiar as
the wind and just as difficult to capture. There is no established treatment protocol for itch; and,
even after nearly a century of investigation, “many mysteries, misconceptions, and controversies
still haunt this rather neglected yet clinically important” sensation (Paus, Schmelz, Biro, &
Steinhoff, 2006, p. 1174). Itch associated with wounds is recognized clinically, but is not
described in the literature related to wounds commonly encountered in wound care practices.
Patients seek measures to prevent, minimize, or eradicate itch related to wounds. Patients, who
are nonverbal and cannot otherwise indicate the sensation of itch, are found scratching at open
wounds. While measures are usually taken to treat pain associated with wounds, complaints of
itch are frequently ignored.

Few studies were found related to itch occurring with wounds

commonly treated in wound care centers. Wounds commonly followed in wound care centers
include vascular, neuropathic, traumatic, pressure-related, and wounds of mixed etiology.
Patients frequently complain that their wounds itch, yet the frequency of wound itch is not
known. Characteristics of wounds that itch, measures taken by persons with wounds to manage
itch, and the effect that wound itch has on quality of life are not known.
Study Purpose
The purpose of this study was to examine itch associated with chronic wounds.

Chronic

wounds commonly followed in wound care practice include vascular (arterial and venous),
neuropathic, traumatic, pressure-related, and wounds of mixed etiology. That these wounds are
considered “chronic” wounds should not necessarily indicate lengthy duration.

Wounds
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commonly followed in wound care centers are considered chronic in that they “have failed to
proceed through an orderly and timely process to produce anatomic and functional integrity, or
proceeded through a repair process without sustaining an anatomic and functional result” as
indicated by Lazarus and colleagues (1994, p. 490). For this study, persons with chronic wounds
were interviewed about their experiences with wound itch and measures they had taken to relieve
itching. Wound itch intensity, location, duration, and aggravating and alleviating factors were
explored. Sensation in the area of the wound and wound characteristics were also assessed.
Rationale for the Study
Since itch is a clinical concern, motivation to learn more about wound itch comes from
encounters with persons who are experiencing wound-associated itch. Persons with wound that
itch describe their suffering and distress. Darsow and colleagues (2001) reported descriptors of
itch chosen by 108 patients with atopic eczema ranged from unpleasant to awful. Itch can be so
disturbing that the person with a wound succumbs to scratching, which can cause further wound
and peri-wound deterioration. Since wound care practice emphasizes healing, prevention of
wound deterioration is crucial.
This study was innovative in that it explored the phenomenon of wound itch, which is
documented clinically, but is not described in the literature. Itch is a multifactorial problem
involving the skin, nervous system, endocrine system, and immune system (Guarneri, Terranova,
Terranova, & Guarneri, 2005). A greater understanding of itch must be gained before options for
therapy can be determined. Nurses need to work collaboratively with other health care providers
to manage the problem of wound itch.
Recent physiologic developments in itch research make this study timely. Andrew and
Craig (2001) documented histamine-selective spinothalamic tract neurons specific for itch
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sensation. They identified itch as a sensation distinct from pain. While pain and itch have many
similarities, especially in intensity of resulting distress, they are, in fact, separate phenomena.
Sun and Chen (2007) published information on an itch-specific mediator, gastrin-releasing
peptide. Additionally, recent advances in neuroimaging techniques have enabled observation of
centers of brain activity in response to induction of pruritus (Herde, Forster, Strumpf, &
Handwerker, 2007; Yosipovitch, Greaves, & Schmelz, 2003). Yet, many questions about wound
itch remain.
Significance to Nursing Theory. Levine’s Conservation Model provides a theoretical
basis for nurses to address the problem of wound itch to conserve the integrity of persons in their
care. Levine contends: “It is the moral duty of the nurse to confront the suffering individual and
bring all the skills of hand, heart, and mind to alleviate it,” (Levine, 1989a, p. 126). Levine
identified the need for nurses to work collaboratively with medicine and other disciplines to
recognize and manage such a mysterious problem as wound itch. This study advances nursing
science by providing an understanding of itch in chronic wounds so that itch might be assessed
and treated to promote healing.
Significance to Nursing and Society. Chronic wounds affect 0.78 % of the population,
with most of those affected being over 60 years of age (Hartoch, McManus, Knapp, & Buettner,
2007). The percentage of adults with chronic wounds is likely to increase with the aging of
society; thus, the number of persons experiencing wound itch may also increase. Function,
psychological state, social interaction, somatic sensation, and financial stability are impacted by
a wound (Baharestani, 2008). Assessment of wound itch and identification of effective treatment
and preventative strategies should improve quality of life for patients with chronic wounds. In
addition, wound care may be less costly as trauma from scratching existing wounds and
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development of new wounds due to scratching can be prevented.
Specific Aims
The specific aims of the study were to: (a) determine the frequency, timing, duration and
intensity of wound itch as experienced by persons with chronic wounds, (b) determine which
wound characteristics (including location, size, depth, type, color) were associated with itch, (c)
identify measures used by persons with chronic wounds to prevent, minimize, or eradicate itch,
(d) describe how wound itch impacts quality of life for persons with chronic wounds, and (e)
distinguish between wound itch and pain.
Research Questions
The research questions answered by this study were: (a) What is the frequency, timing,
duration and intensity of itch related to chronic wounds? (b) What is the relationship between
wound characteristics and itch? (c) What measures do persons with wound itch use to manage
wound itch? (d) How does wound itch affect quality of life for the participants? (e) What is the
relationship between wound itch and pain?
Variable Definitions
Wound. A wound is defined as “a disruption of the integrity and function of tissues in
the body” (Baharestani, 2008, p.3). Chronic wounds include vascular (arterial and venous),
neuropathic, traumatic, and pressure-related wounds as well as wounds of mixed and other
etiologies as may be found among people seeking treatment at wound care centers. An arterial
wound results from tissue ischemia due to inadequate blood supply and typically presents as a
painful, pale wound with well-defined wound edges (Doughty & Holbrook, 2007). A venous
wound results from chronic venous insufficiency and typically presents as a ruddy wound with
irregular wound edges (Doughty & Holbrook, 2007). Neuropathic wounds are often found on
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feet of persons with diabetes mellitus and are often surrounded with callus (Driver, Landowski,
& Madsen, 2007). A traumatic wound results from a traumatic event which causes injury to the
skin and, possibly, deeper tissues and underlying structures. A pressure-related wound results
from sustained pressure to an area to such a degree or length of time that injury to underlying
skin occurs (Pieper, 2007). Pressure-related wounds of interest include those classified as Stage
II through Stage IV (NPUAP, 2007). Stage II ulcers involve partial-thickness loss of dermis
which presents as a shiny or dry shallow ulcer. Stage III ulcers involve full-thickness tissue loss
without visible muscle, tendon, or bone. Stage IV ulcers involve full-thickness skin loss with
exposed bone, tendon or muscle. Stage I pressure ulcers do not involve any open wounds in the
skin and, so, are not included. Other types of wounds are burns (tissue trauma due to thermal
injury), fungating wounds as develop with malignancies, and wounds with mixed etiology (as
with concomitant arterial and venous disease). Extensive burns are usually not followed at
wound care clinics as persons with extensive burns are typically referred to a burn center.
Wounds are described by many defining characteristics including location, size (length, width,
and depth), peri-wound descriptors (color, integrity, temperature, and texture), color, odor,
moisture, drainage, base material (e.g., granulation tissue, eschar, slough, subcutaneous tissue,
muscle, bone, and tendon). As previously described, wounds commonly followed in wound care
practices are considered chronic in that they do not follow the normal and timely process of
healing to return to a normal anatomic and functional result (Lazarus et al., 1994).

This

definition of chronic wounds has been accepted by the Wound Healing Society (Gottrup, Nix &
Bryant, 2007). Acute wounds, such as surgical wounds which heal in an orderly and timely
manner, are not typically followed in wound care practices.
Itch. More than 340 years ago a German physician, Samuel Hafenreffer, defined itch as
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an unpleasant sensation that elicits the desire to scratch (Ikoma, Steinhoff, Stander, Yosipovitch,
& Schmelz, 2006). Although the adjective “unpleasant” is very subjective, the definition has
persisted.

Greaves and Khalifa (2004) further clarified that itch is:

“a complex,

multidimensional experience involving a range of different qualities of sensation, such as
pleasurable relief by local physical intervention, which leads to itch/scratch cycles and
modulation by cognitive and psychological functions from higher centers” (p. 166). Itch can be
defined as “1) an irritation of the skin, 2) an impatient desire: a hankering” (Hawkins & Allen,
1991, p. 755). Stedman’s Medical Dictionary defines itch as “an irritating sensation in the skin
that arouses the desire to scratch” (2006, p. 1008). Some distinctions have been made between
itch and pruritus. Waxler and colleagues (2005) specify that pruritus is a condition in which itch
is present without a specific cause. Often pruritus is used to indicate itch without visible skin
lesions; however, arguments can be made for itchy conditions in which rubbing enables tolerance
without visible skin lesions (Bernhard, 1994). Itch and pruritus are synonymous (Bernhard,
1994). Throughout this paper the two terms are used interchangeably. Itch is generally a
sensation of the skin, but in this study, itch was related to wounds, which were often through the
skin and deeper than the skin. Wound itch, then, is the irritating sensation or disturbing feeling
related to an open wound, including the wound bed and the skin immediately surrounding the
open wound. Wound itch is synonymous to wound-related itch. While wound itch might be
impacted by systemic conditions which cause itch, steps were taken to distinguish wound itch
from itch due to other causes.
Quality of Life. Weldon (2006) defined health-related quality of life as a person’s
assessment of current level of functioning and/or satisfaction with state of being as well as what
the person perceives as ideal. Quality of life is a subjective phenomenon which encompasses
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physical as well as psychological well-being. Aspects of quality of life which can be impacted
by wound-related itch include physical/occupational functioning, psychological state, social
interaction, somatic sensation, and financial stability (Baharestani, 2008). While chronic wounds
impact quality of life, itch related to wounds may further impact quality of life.
Summary
Itch related to chronic wounds has not been described well in the literature. The purpose
of this study was to explore wound itch to add to the current understanding of itch so that,
ultimately, therapies can be developed to manage wound itch. Management of wound itch would
promote wound healing for improved quality of life for persons with chronic wounds and cost
saving related to wound care.
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CHAPTER II
Background
In this chapter, a summary of what is known about itch, especially as it occurs with
wounds, is presented as a background for the study.

Topics include itch classification,

physiology of itch, neuronal pathways, pathophysiological causes of itch, pruritogens,
antipruritics, effects of itch on quality of life, and measurement of wound itch.
Review of Literature
Classification of Itch
The classification of itch based on duration or source has proven to be inadequate. Acute
itch can last from seconds to a week (Yosipovitch & Greaves, 2004). Chronic itch is generally
considered that itch which lasts longer than six weeks (Stander et al., 2007). Twycross and
colleagues (2003) proposed a classification system for itch based on underlying mechanism; this
has been used successfully. In this classification system, itch can be pruritoceptive (peripheral,
cutaneous, dermatological), neurogenic (central, caused by systemic disorders), neuropathic
(from diseased neurons as in multiple sclerosis), psychogenic (mind-related, as with parasitosis),
and mixed (with overlapping causes). Pathophysiological conditions can trigger multiple types
of itch.
Pruritoceptive itch. Pruritus classified as pruritoceptive (also referred to as cutaneous,
dermatological, or peripheral) includes the itch of atopic dermatitis, psoriasis, drug reactions,
mites, urticaria, xerosis, and other inflammatory dermatoses (Ikoma et al., 2006). This study of
itch associated with wounds was concerned with pruritoceptive itch.
Neurogenic itch. Neurogenic itch is associated with systemic conditions, including
chronic liver disease and chronic renal failure (Ikoma et al., 2006). With chronic liver disease,
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the accumulation of bile salts has been studied as a cause of pruritus, but a central mechanism of
endogenous opioid peptides produced by the liver has been proposed as the likely cause of
pruritus (Greaves, 2005; Twycross et al., 2003). The cause of itch with renal failure remains
unknown (Greaves, 2005). Pruritus with uremia (chronic renal failure) is not as severe when a
more permeable dialysis membrane is used suggesting that a less permeable membrane causes an
accumulation of pruritogens (Twycross et al., 2003). A multitude of underlying factors with
uremia have been considered. The excessive skin dryness found with end-stage renal disease is
usually part of the itch problem. Human immunodeficiency virus (HIV) often results in itch via
multiple etiologies. Itch in HIV is likely related to disruption of normal immune function
resulting in systemic and cutaneous causes (Duque, Yosipovitch, & Pegram, 2004). Many
malignant and hematologic conditions present with pruritus (e.g., polycythemia vera, leukemia,
multiple myeloma, and Hodgkin’s lymphoma) (Greaves, 2005; Twycross et al., 2003).
Generalized pruritus can precede the onset of Hodgkin’s disease by up to five years (Weisshaar,
Kucenic, & Fleischer, 2003). Nasal pruritus is an indicator of brain malignancy (Weisshaar et
al., 2003; Yosipovitch, Goodkin, Wingard, & Bernhard, 2004). Hyper- and hypothyroidism
often induce itch; dry skin is usually the problem in hypothyroidism (Greaves, 2005).
Neuropathic itch.

The third type of pruritus, neuropathic pruritus, results from

pathology along the afferent neuronal pathway as with post-herpetic pruritus, multiple sclerosis,
and diabetic neuropathy (Ikoma et al., 2006). In these conditions, the neural pathways are
affected by the disease process, and the result is the sensation of itch.
Psychogenic itch. Psychogenic itch is associated with psychological factors. Mindrelated influence on the itch sensation is demonstrated in the fact that with distraction itch can be
forgotten; with training, itch can be suppressed (Twycross et al., 2003). That itch is socially
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contagious (similar to yawning) points to central rather than peripheral mechanisms.
Itch of mixed etiology. Itch may be classified as having mixed etiology when multiple
factors may be causing it. For example, itch associated with eczema might be considered mixed
in that it involves an auto-immune pathological process (as with neurogenic itch) and is
exacerbated by stress (as with psychogenic itch).
Physiology of Itch
Until 1997, the sensation of itch was thought to follow the same pathways that painful
stimuli followed, but with a less intense stimulus eliciting itch rather than pain. Subsequently,
itch-selective neurons were found in humans (Stander & Schmelz, 2006). Itch can be inhibited
by painful stimuli such as thermal (hot water), mechanical (scratching), or chemical (histamine)
means. Analgesia (by reducing inhibition) may actually cause itch (Stander & Schmelz, 2006;
Waxler et al., 2005). Slow-conducting C-fibers which originate in the skin (a subclass of Cnociceptors for pain) pass sensory information to the dorsal horn of the spinal cord and, via the
spinothalamic tract, on to the thalamus in the somatosensory cortex (Heymann, 2006; Paus et al.,
2006; Twycross et al., 2003; Waxler et al., 2005). The slow-conducting C-fibers (pruriceptors)
account for approximately five percent of all afferent C-fibers in human skin (Heymann, 2006).
These itch-sensing C-fibers are similar to, but functionally distinct from, pain fibers. The Cfibers are responsive to histamine and other pruritogens, but are insensitive to mechanical stimuli
(Heymann, 2006). Pruritogens that are likely present in open wounds include histamine, which
is released from granulation tissue and growth factors (Baker et al., 2001; Stander et al., 2003;
Twycross et al., 2003). (These pruritogens will be discussed later in the paper.) When free nerve
endings of the specialized C-fibers are stimulated by pruritogens, itch is induced.
Genetic Aspects of Itch
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Sun and Chen (2007) examined thermal, mechanical, inflammatory, and neuropathic pain
responses in gastrin-releasing peptide receptor (GRPR) mutant mice and found that there was no
difference in response when compared to responses of unaltered wild mice to noxious stimuli.
Scratching behavior was induced with injection of compound 48/80 (a mast cell degranulator), a
PAR-2 agonist (a mediator of itch in human skin), and chloroquine into both groups of mice.
PAR-2 and chloroquine are believed to act independently of histamine, and the reduction in
scratching behavior was much more apparent with PAR-2 agonist (p < .05) and chloroquine (p <
.01) than with compound 48/80. The number of scratches was significantly less in the GRPR
mutant mice in response to injection of known pruritogens. Those differences were not found
with pain-inducing agents.

Intrathecal injection of GRPR agonist induced dose-dependent

scratching behavior. Swain (2008) noted that gastrin-releasing peptide (GRP) participated in
transmission of the itch sensation but not in the pain sensation. GRP was found in a small subset
of dorsal root ganglion neurons with expression of its receptor restricted to lamina I of the dorsal
spinal cord, consistent with the current model of itch sensation central processing.
Gastrin-releasing peptide (GRP) and GRPR are found throughout the central nervous
system and gastrointestinal tract (Ischia, Patel, Shulkes, & Baldwin, 2009).

GRP is a

neuropeptide. The gene for GRP is located on chromosome 18. GRP and its receptor are
involved in many physiological functions including exocrine and endocrine secretions,
regulation of body temperature, maintenance of blood pressure, smooth muscle contraction,
exocrine and endocrine secretions, pain transmission, satiety, and behavior (Ischia et al., 2009).
Precursors of GRP have been found to function as biomarkers for small-cell lung cancer and
prostate cancer.
Neuronal Pathways for Itch
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Sensory receptors in the skin include free and corpuscular nerve endings. Corpuscular
endings include both nonencapsulated Merkel’s touch spots and encapsulated receptors (Metze,
2004).

It has not yet been possible to morphologically differentiate nociceptors from

pruriceptors (Schmelz, 2005). Neurophysiologic techniques for identifying specific sensory
activity within individual terminal axons are not yet refined, so there is still speculation about
specific sensory functions of nerve endings. The free nerve endings of unmyelinated C-fibers
and small myelinated A-fibers are the sensory fibers in humans. These free nerve endings are
found in the papillary dermis and epidermis (Stander et al., 2003). Interestingly, itch is not
inducible where epidermis has been removed (Metze, 2004), so itch sensed within wounds is
difficult to explain. Itch is specific to the skin, mucus membranes, and cornea (Yosipovitch &
Papoiu, 2008).
In a breakthrough study, Schmelz and colleagues (1997) reported iontophoresis with
histamine induces itch sensation.

The study involved 53 healthy (human) volunteers.

Iontophoresis was accomplished by delivery of current through an electrode which was within an
applicator. The applicator contained histamine dihydrochloride dissolved in a gel. The current
went to a reference electrode on the skin. Microneurography (a method involving electrical
search stimuli) showed discharge patterns matching the time course of itch. These discharge
patterns for the itch sensation were found in eight neuronal units which had three distinguishing
characteristics: mechanical insensitivity, slow conduction velocities (average 0.5 m/s), and large
innervation territories. These neuronal units were determined to be the afferent units responsible
for mediating the itch sensation. Burning pain, heat, and itch are transmitted through these Cfibers (Stander et al., 2003). However, it is not likely that all types of itch sensation are
transmitted through these C-fibers.

Johanek and colleagues (2007) were interested in itch
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induction by pruritogens which did not produce the characteristic flare that accompanies
histamine. They looked for differences in reactions to histamine versus cowhage spicules.
Doppler results showed large areas of vasodilation around histamine versus vasodilation only at
the site of cowage application. Topical capsaicin abolished cowhage-induced itch but had no
effect on histamine-induced itch; while pre-treatment of skin with an antihistamine prevented
itch at the site of histamine application, but did not prevent cowhage-induced itch. Their
findings implicate a group of afferent fibers that are separate from the histamine-sensitive,
mechano-insensitive C-fibers for itch sensation.
The primary neurons (histamine-sensitive and mechano-insensitive) synapse via dorsal
root ganglia with second-order neurons in the dorsal horn of the spinal cord (Waxler et al.,
2005). At the spinal level, spinothalamic projection neurons transmit pruriceptive information
via neuronal pathways which are likely specific for itch (Stander et al., 2003). Unlike pain, itch
does not provoke a spinal reflex (Stander et al., 2003). The secondary neurons cross over to join
the contralateral spinothalamic tract and ascend to the thalamus where they synapse with thirdorder neurons for transmission to the somatosensory cortex of the post-central cingulate gyrus
(Stander et al., 2003; Twycross et al., 2003; Waxler et al., 2005). Scratching is controlled by an
area of the medulla (Stander et al., 2003; Yosipovitch & Papoiu, 2008).
Andrew and Craig (2001) used histamine on the lumbosacral spinal cords of 33
anesthetized cats to categorize neurons into functional categories.

They were able to

demonstrate a functionally unique subset of histamine-selective lamina I spinothalamic tract
neurons in the cats which match the response of human neurons to the itch sensation. The
matched response supports the notion of itch as a specific sensation. The conduction velocities
of the histamine-sensitive neurons were significantly slower than the conduction velocities of the
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other neurons, and their electrical thresholds were higher.
No single “itch center” in the brain has been identified (Darsow, Drzezga, & Ring, 2004).
Positron emission tomography (PET) has enabled the study of supraspinal processing of itch
(Yosipovitch, Greaves, & Schmelz, 2003). The multidimensionality of itch is indicated as
multiple areas of the brain are activated when itch is induced. Drzezga and colleagues (2001)
used PET scanning to study the central processing of histamine-induced itch. They noted
significant activation of contralateral somatosensory cortex, as well as contralateral and
ipsilateral motor areas, but no thalamic activation. Yosipovitch and colleagues (2003) saw that
with histamine skin pricks, the anterior cingulate cortex, supplementary motor area and inferior
parietal lobe are activated. That the limbic and motor areas are activated supports the clinical
observation that itch elicits the desire to scratch. Findings of these studies show that thalamic
and somatosensory cortex activation is not seen when itch is induced as it is when pain is
induced.
Itch Versus Pain
Pain and itch are difficult phenomena to separate. Although subjects in the studies
described in this review reportedly denied it, some pain was surely sensed as microdialysis
catheters or skin pinpricks were performed for itch induction. Thalamic activation was noted in
the fMRI studies (discussion following), in contrast to findings of the PET studies as discussed
previously. Differences between pain and itch processing are likely not related to activation of
different areas of the brain, but, rather, to activation of the same areas with different activation
patterns as in the Pattern Theory (Paus et al., 2006).
Two forms of central sensitization associated with pruritus are similar to pain
sensitization: punctate hyperkinesis and allokinesis. Punctate hyperkinesis is an intense itch
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sensation that occurs in an area surrounding itch induction and is similar to punctate hyperalgesia
as found with chronic pain (Yosipovitch & Papoiu, 2008). Allokinesis is a phenomenon of
intensely itchy skin, which is induced by touching an area around an itching site, and is similar to
allodynia in which contact with skin causes pain in chronic pain conditions.
Phantom itch is a phenomenon recognized with pain which may have implications for
wound itch.

Phantom pain is a well-recognized phenomenon, but phantom itch is not

(Yosipovitch et al., 2004). Lierman (1988) interviewed 27 women in a Reach for Recovery
program during their first year post-mastectomy to describe phantom sensations experienced
post-mastectomy and to describe women’s responses to the experience. Sixty percent of the
women interviewed had phantom sensations, with the most common sensation being itch. Four
of seven women who experienced nipple sensations experienced itch. Jacome (1978), in a case
study, described a patient with bilateral below-knee amputations who was only able to relieve
severe phantom itching in the area where his feet would have been by scratching in that area:
scratching the stumps provided no relief. Melzak (1992) proposed a neuromatrix, a network of
neurons, which generates a characteristic pattern of impulses to indicate that the body is intact
with its belonging parts creating what he called a neurosignature. The neuromatrix might signal
in the absence of sensory inputs to create the phantom sensations. Bernhard (1992) adds that the
brain must rely upon the skin for sensory input as the skin determines the boundaries of the self.
Phantom itch might occur even where the body is intact and may explain senile pruritus (the
common problem of unexplained itching in the elderly).
Functional magnetic resonance imaging (fMRI) studies have shown involvement of
forebrain regions with itch induction including Brodman areas 10, 21, 22, and 40 and the
cerebellum (Yosipovitch et al., 2003). Herde, et al. (2007) used fMRI to correlate blood-oxygen-
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level dependent (BOLD) effects with 10 subjects’ ratings of itch as a histamine-codeine mix was
applied through microdialysis fibers. Codeine was added to promote histamine release from
endogenous mast cells.

BOLD effects were compared in response to itch induction and heat

pain. Itch stimulated more areas of activation than pain, particularly on the contralateral side of
the brain. Negative BOLD effects were noted in the anterior cingulate cortex and amygdala,
likely related to the urge to scratch.
Studies of scratching have added further to the understanding of pruritus. For study
purposes, scratching has been imitated by repetitively moving a cytology brush over an area with
enough force to bend the skin-facing brush bristles (equivalent to 29 g of force on a digital scale)
(Yosipovitch et al., 2008). Yosipovitch and colleagues (2008) used fMRI on 13 healthy human
subjects who received scratching stimuli to the right lower leg. They determined that scratching
may mediate inhibition of itch by deactivating the anterior cingulate cortex and posterior
cingulate cortex, providing relief by suppressing the emotional components of itch.

The

cerebellum has been associated with motor and sensory coordination, and activation of this area
as was seen in the scratch study may result from its sensory coordination activities (Yosipovitch
et al., 2008).

Davidson and colleagues (2009) examined whether responses to histamine in

primate (monkey) spinothalamic tract (STT) neurons could be inhibited by scratching in the
receptive field. They found that scratching provides relief of itch by reduction in the discharge
rate of STT neurons, which are responding to an itch-producing stimulus. Yosipovitch and
colleagues (2007) had 21 healthy subjects rate histamine-induced itch sensation with innocuous
warmth, innocuous cool, noxious cold, and noxious heat applied distal to the area of histamine
iontophoresis. Scratching, noxious heat, and noxious cold significantly reduced ratings of itch
intensity. Additionally, their observations indicate that thermal and mechanical modulators of
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histamine-induced itch do not require direct physical interaction with the area from which the
itch originates: scratching distal to the site of origin relieved the itch (with implications for
treatment of wound-related itch).
In contrast to pain, itching causes a nocifensive withdrawal response to remove the
offending irritant and protect the skin and integrity of the body (Paus et al., 2006). The itchscratch cycle is described in which itch elicits a scratch response (Stander et al., 2003;
Yosipovitch & Hundley, 2004). The scratching causes inflammation and further stimulation of
nerve fibers which results in the sensation of itch. The sensation of itch then prompts further
scratching or rubbing. While scratching and rubbing can provide relief, both can also lead to
lichenification (scratch marks) and further trauma (Davidson, Zhang, Khasabov, Simone, &
Giesler, 2009; Yosipovitch & Hundley, 2004).
Summary of Itch Physiology
Recent scientific advances have greatly added to our understanding of itch: itch-specific
neurons, spinothalamic tracts specific to itch processing, genetic mediators for the itch sensation,
cerebral processing which is similar to, but distinct from, pain processing. These findings
suggest the need to further explore itch clinically as a distinct phenomenon.

This study

attempted to distinguish wound-related itch from other wound-associated sensations.
Pruritogens
A number of endogenous and exogenous pruritogens (itch triggers) have been identified.
These pruritogens may be found in the body of the itching person, even in the wound bed, or
may be in the environment of the itching person.

Individual itch response to the various

pruritogens varies between individuals. The discussion of pruritogens which follows is not
exhaustive, as it is possible for any stimulus to trigger itch.
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Endogenous Pruritogens
Histamine. Histamine is released as degranulation of dermal mast cells occurs and
directly stimulates histamine type 1 (H1) receptors on itch-specific C-fibers (Twycross et al.,
2003). Histamine is often used to elicit itch as the reaction to histamine is predictable.

The

reaction includes an itch which begins 30 to 45 seconds after histamine application and resolves
over 10 to 15 minutes, a wheal which develops over eight minutes, and a surrounding flare. The
wheal and flare are specifically histamine mediated.
Leknes and colleagues (2007) used fMRI to compare allergen- and histamine-induced
itch in terms of skin blood flow changes and central processing. Responses to skin prick tests
done with histamine and allergens on 14 healthy subjects were compared. Both types of itch
correlated with activity in the anterior cingulate, striatum and thalamus. Additionally, itch
elicited by allergens resulted in activation of orbito-frontal, supplementary motor, and posterior
parietal areas. Histamine-induced itch resulted in activation of the insula bilaterally. Allergen
induced itch was perceived as more intense and enduring (p < .005), while histamine-induced
itch intensity faded more quickly. Perceived itch intensity and blood flow occurred significantly
later in response to allergen-induced itch than to histamine-induced itch (p < .001).
Acetylcholine.

Acetylcholine is a neurotransmitter which, via muscarinic and

nicotinergic receptors, causes pain in non-atopic persons, but itch in atopic persons (Twycross et
al., 2003). Apparently, the activation of itch units by acetylcholine does not provoke itch in nonatopic persons due to simultaneous activation of non-itch receptors which suppress the itch
(Schmelz & Handwerker, 2004). A flare response to intradermal acetylcholine is less than, but
similar to, that induced by histamine.
Serotonin. Serotonin induces itch via 5-HT3 receptors (Stander et al., 2003). Selective
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serotonin reuptake inhibitors (SSRI) have antipruritic effects (Pogatzki-Zahn, Marziniak,
Schneider, Luger, & Stander, 2008). Serotonin is a mediator in psychogenic itch (Ikoma et al.,
2006).
Bradykinin. Bradykinin, with bradykinin receptors, lowers the receptor threshold and
causes pain (Pogatzki-Zahn et al., 2008). However, bradykinin induces mast cell degranulation
for the release of histamine and enhances histamine responses so contributes to the itch sensation
(Stander et al., 2003).
Prostaglandins.

Prostaglandins potentiate histamine-induced itch by lowering the

receptor threshold to histamine and papain (Pogatzki-Zahn et al., 2008; Stander et al., 2003).
Interleukins. Interleukins (IL-2, IL-4, IL-6, and IL-31) are cytokines, which originate in
t-cells and macrophages (Ikoma et al., 2006). Interleukins play a role in the elicitation of itch,
similar to histamine, by activating the cutaneous C-fibers (Stander et al., 2003). Interleukin-31
induces pruritic dermatitis in mice (Ikoma et al., 2006). The role of interleukins in itch behavior
is still being determined.
Nerve Growth Factor. The role of nerve growth factor is speculative, but may lead to
sensitization of peripheral nerve fibers (Pogatzki-Zahn et al., 2008).

A direct correlation

between nerve growth factor and pruritus has not been found, but increased plasma levels of
nerve growth factor have been found in patients with atopic dermatitis (Stander et al., 2003).
Nerve growth factor is elevated in traumatized tissue (Schmelz, 2012).
Substance P. Substance P (neurokinin1) is a neuropeptide, released from sensory nerve
fibers by type-2 proteinase-activated receptors (PAR-2) and appears to potentiate itch by
releasing histamine from dermal mast cells (Greaves & Khalifa, 2004; Twycross et al., 2003).
Topical capsaicin depletes substance P from cutaneous nerve terminals and destroys C-fibers to
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relieve itch.
Stress. There is some understanding of neurogenic inflammation and the influence of
stress on pruritic skin conditions (Gieler, Niemeier, Brosig, & Kupfer, 2002). Neurotrophic
factors such as nerve growth factor, which can modify expression of inflammatory cytokines by
mast cells, have been found to be stress-inducible. Also, there is evidence that, in stress states,
keratinocytes influence non-myelinated nerve fibers in the epidermis through beta endorphin
production by propiomelanocortin.
Exogenous Pruritogens
Chemical Stimuli.

Botanicals including poison ivy, stinging nettles, and cowhage

spicules induce itch. Latex, a plant derivative, can cause pruritus. Cosmetics and soaps can
cause irritant and allergic reactions. Insect bites and parasite infestations (i.e. scabies) are
familiar pruritogens. Many drugs, including opiates, aspirin, and beta blockers can induce
pruritus without a rash (Yelverton & Yosipovitch, 2007).
Physical Stimuli. In addition to chemical pruritogens, there are numerous physical
stimuli which can elicit itch. Light touch, pressure, suction, heat, and electrical stimulation can
induce itch (McMahon & Koltzenberg, 1992). Wool fibers, fiberglass, and water (“aquagenic
pruritus”) can cause itching in some people (Yelverton & Yosipovitch, 2007).
Research Related to Itch Occurring with Chronic Wounds
Research related to xerosis (dry, rough skin commonly found in elderly persons), venous
ulcers, and burns is sparse. Itch related to arterial, neuropathic, traumatic and pressure-related
wounds could not be found.
Xerosis
Norman (2003) looked at diagnoses with ICD-9 codes of 1,556 nursing home residents to
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determine common problems and found pruritus (n = 1002) and xerosis (n = 772) to be the two
most common problems among those persons. Norman describes xerosis (dry skin) with pruritus
in the elderly, most commonly in the legs, but also in the hands and trunk. Xerosis follows a
pattern of flaking, fissuring inflammation, dermatitis, and infection. Methods and results were
not well described, but pharmacologic treatment options are discussed.
Pacifico and colleagues (2005) conducted a quasi-experimental study to evaluate the
effectiveness of a lotion containing menthol and colloidal oatmeal in treating itch associated with
xerosis. Comparison of changes was made between baseline and post-treatment scoring of 54
patients who used Aveeno Skin Relief Moisturizing Lotion ® daily for three weeks.
Improvement in itch was found in 52 of 54 patients. 
Venous Ulcers
Shai and Halevy (2005) questioned, and reviewed medical records of, 91 persons who
had a total of 110 venous ulcers to determine what actually causes ulceration in persons with
venous insufficiency. The non-experimental study involved history taking and chart review.
They concluded that 5.4% of the ulcers were triggered by dry skin with subsequent scratching.
No trigger was identified in 26.3% of the ulcers.
Hareendran and colleagues (2005) interviewed 38 persons with venous ulcers to identify
health-related quality of life issues in those persons. They found the ulcers resulted in pain
(80.5%), itching (69.4%), altered appearance (66.7%), loss of sleep (66.6%), functional
limitations (58.3%), and disappointment with treatment (50%). It is not known how much itch
specifically impacted sleep or functional limitations.
Hareendran and colleagues (2007), in a separate study, conducted in-depth interviews and
focus groups with 36 patients who had venous leg ulcers. Their goal was to develop and validate
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a quality of life questionnaire. Symptom severity and bother were assessed. Bother included
pain, smell, itching, sleep disturbance, and restrictions from daily activities. “Ulcer itches” was
ranked fourth among 10 symptoms causing distress, after ulcer burns/stings, ulcer hurts, and skin
irritated (Hareendran et al., 2007).
Duque and colleagues (2005) conducted a study among persons with mild to moderate
venous insufficiency to estimate prevalence of itch, pain and burning sensations, to examine
characteristics of the symptoms and their relation to severity of venous disease, to identify
factors that aggravate or alleviate the symptoms, and to determine impact of itch on quality of
life in these persons. The Clinical Signs, Etiology, Anatomic Distribution, Pathophysiologic
Condition (CEAP) classification system was used for determining eligibility to participate and
for grading venous disease. Sixty-six percent of subjects had itch at the time of the interview.
Itch did not correlate with severity of venous disease, but there was a significant negative
relationship between itch intensity and quality of life.
Paul, Pieper, and Templin (2010) conducted a pilot regarding itch by adding questions
about itch during the data collection portion of Dr. Pieper’s study, which was funded by the
National Institute of Health, entitled “Effect of Drug Use on the Legs:

Chronic Venous

Insufficiency, Mobility and Pain” RO1 NR009264. The larger study explored chronic venous
disease, mobility and pain in persons in methadone treatment. Results of the pilot, which
included 161 persons, showed that itch increased significantly with an increase in severity of
symptoms of chronic venous disease (r = .26, p = .025) (Paul et al., 2010). Fourteen of the
participants had wounds; of the 14, five (41.7%) used antibiotic ointment, and four (33.3%) used
petrolatum to manage itch.
Burns
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Most of the wound itch studies found described itch associated with burns. Itching
associated with acute burns as well as healed burns will be discussed. Burn associated itching
usually peaks at two to six months post-burn and often resolves with scar maturation (often 12 to
18 months) (Demling & DeSanti, 2001).
Bell and colleagues (1988) administered a questionnaire to nurses who specialized in
burn care (number not specified) to determine if they viewed itching as a problem for burn
patients and to determine treatment regimens to decrease discomfort from itch. Most nurses in
burn care believed itching was a significant problem for their patients. Antipruritic medications
and lotions were the most frequently used therapies (approximately 94% and 88%, respectively).
Three studies were found which discussed itch in healed burns. Field and colleagues
(2000) compared patients with burn injuries receiving standard therapy (including cocoa butter
application by occupational therapists) to patients receiving massage therapy (cocoa butter
applied with the massage). They used a visual analog scale to rate itch in 20 adult patients
whose burns were in the remodeling phase of healing: massage therapy resulted in a significant
reduction in itching (p < .001 first day of massage and p < .005 last day).

Anxiety and

depression were also reduced with massage therapy.
Kopecky and colleagues (2001) conducted a study to determine the safety and
pharmacokinetics of EMLA (eutectic mixture of local anesthetics) for treatment of burn itch.
The number of pruritic episodes and antihistamine breakthrough doses were compared between
pre-treatment days and treatment day, and significant reduction was found (p = .01 and p = .03,
respectively). Five children who had burns with newly formed skin experienced reduced itch
with application of EMLA.
Demling and DeSanti (2001) tested the efficacy of doxepin cream for 20 adults with
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resistant burn pruritus. A pain scale was used to determine that pruritus was significantly
decreased by use of topical doxepin (p < .05). The study had a small sample size with no control
group or randomization, and a placebo effect was possible.
In an experimental study by Hettrick and colleagues (2004), transcutaneous electrical
nerve stimulation (TENS) therapy significantly decreased itch in healed burns of 20 adults (p =
.086). This study had a small sample size. Reliability of subjects’ method of TENS use or of the
visual analog scale used to measure itch was not discussed.
Three studies were found concerning itch in acute burns. Baker and colleagues (2001)
burns: the best response was found with the use of cetirizine with cimetidine. Matheson and
colleagues (2001) were looking for a method to reduce itch as experienced with burns. They
assessed itch rating of 35 acute burn patients who tried one of two bath oils: one with colloidal
oatmeal and one without. Persons using the bath oil with colloidal oatmeal reported a daily
mean itch value, which was half as much as the mean itch value reported by those using the oil
without colloidal oatmeal.
Mendham (2004) was interested in seeing if itching would respond to medications as
used for neuropathic pain and, so, observed episodes of itching in 35 children with acute burns.
He found that a marked reduction in episodes of scratching was noted with gabapentin use.
Ratcliff and colleagues (2006) reviewed charts of 286 children with acute burns and determined
that their itch had been well controlled. Interventions taken to manage itch were not described.
Quality of Life as Impacted by Wounds and Itch
Studies which examined wound itch and quality of life were not found. Studies which
looked at quality of life related to wounds and studies which looked at quality of life related to
itch are reviewed. Most of the studies which had findings related to quality of life with itch were
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conducted for instrument development. Few instruments have been developed related to itch,
and the impact of wounds on quality of life is not thoroughly understood. The problems of
wounds and itch both negatively affect quality of life as is seen in related literature.
Impact of Wounds on Quality of Life
Venous Ulcers. Walshe (1995) conducted a qualitative study among 13 persons with
venous ulcers to describe the experience of living with a venous leg ulcer from the patient’s
perspective. A phenomenological approach to data collection and analysis was used. She found
that these persons suffered with pain, wound leakage and smell, embarrassment, and difficulty
maintaining dignity. Findings pointed to the importance of comfort and symptom management
for persons with venous leg ulcers.
Pieper, Szczepaniak, and Templin (2000) were interested in psychosocial adjustment,
coping, and quality of life in persons with venous ulcers and a history of intravenous drug use.
They collected information on quality of life from 32 persons with venous ulcers and a history of
intravenous drug use. The area of the wound was inversely related to quality of life (r = -.52).
Interference from pain also negatively affected quality of life (r = -.65, p < .001). They found
that both wound area and pain were associated with difficulties in the home.
Persoon and colleagues (2004) conducted a meta-analysis of studies concerning leg
ulcers to gather information on patients’ perspectives of the impact of leg ulcers on daily life.
Thirty-seven qualitative and quantitative studies were included in the meta-analysis. Leg ulcers
were found to pose a threat to physical and social function. Compared to healthy people, persons
with leg ulcers had significantly poorer quality of life. Women had lower quality of life scores
than men.
Neuropathic Ulcers. Armstrong and colleagues (2008) studied quality of life among 63
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persons with neuropathic diabetic plantar foot ulcers. The participants were randomized to one
of three offloading modalities. Quality of life questionnaires (SF-36) were administered before
and after a 12-week study period. Quality of life seemed to be more dependent on whether or
not the wound healed than on which treatment was used.
Pressure Ulcers. Spilsbury and colleagues (2007) interviewed 23 hospital inpatients to
explore their perceptions and experiences associated pressure ulcers. They were interested in the
impact of pressure ulcers and treatment on health and quality of life. Twenty-one participants
(91%) indicated that the pressure ulcer and its treatment affected their lives emotionally,
mentally, physically, and socially.

The researchers pointed out the difficulty that was

encountered in distinguishing the impact of pressure ulcers from the impact of the participants’
multiple co-morbidities.
Essex and colleagues (2009) conducted a study to determine the impact of pressure ulcers
on health-related quality of life. Data from 218 people with pressure ulcers was compared with
data from 2,289 persons without pressure ulcers who had completed the Short-Form 36 (SF-36).
Age, gender, and co-morbidities were controlled. Persons with pressure ulcers had lower scores
for the physical (p < .001) and mental (p = .04) component summary scores. Analysis was
limited in this study also related to categorization of co-morbidities. Consistency of methods for
categorization of co-morbidities was recommended.
Impact of Itch on Quality of Life
Malignant Wounds.

Maida and colleagues (2009) studied 67 cancer patients who

demonstrated malignant wounds at the time of referral for palliative care. Patients’ self-reports
of up to three wound-related symptoms were studied. Of eight main symptoms, the point
prevalence for pruritus was 6%. Interestingly, pruritus was reported within the wound itself as
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well as in the peri-wound area. Other identified symptoms included pain, mass effect, esthetic
distress, exudate, odor, bleeding, and crusting.
Skin Diseases. The Dermatology Life Quality Index (DLQI) was developed for persons
with dermatological conditions to measure the impact of skin disease and its treatment on quality
of life (Finlay & Khan, 1994). It consists of 10 items and is simple to administer. Outpatients (N
= 120) with a variety of dermatologic conditions completed the DLQI. Different aspects of life
affected by their skin diseases were explored. The areas of impairment caused by the skin
condition included self-conscious (n = 24), sore/painful/stinging (n = 21), itching (n = 20),
embarrassment (n = 20), leisure activities affected or limited (n = 14), and difficulties making
new relationships (n =14). The scores for the persons with itchy conditions including atopic
eczema (41.7%), generalized pruritus (30.2%), and psoriasis (29.7%) were higher than scores of
persons with viral warts (22.2%) and acne (14.4%). These higher scores indicated a greater
number and severity of perceived problems for the persons with itchy conditions.
Verhoeven and colleagues (2007) evaluated questionnaires from 492 persons with
various skin diseases about itch, pain, and fatigue to evaluate the prevalence of physical
symptoms. Itch (53.5%) and fatigue (52.4%) were more frequently occurring than pain (23.0%)
among those persons with skin diseases.
Dawn and colleagues (2008) conducted a study in which 304 persons with atopic
dermatitis completed the web-based Characteristics of Itch Questionnaire to examine the
frequency, intensity, and perceived characteristics of itch. A statistically significant (p < .001)
positive correlation between itch descriptors and itch intensity was found. Strong adjectives
were selected by participants to depict the intense degree of suffering and unpleasantness they
experienced (e.g., annoying and bothersome).

28

Uremic Pruritus.

The short form of the McGill Pain Questionnaire was used by

Yosipovitch and colleagues (2001) to develop and validate a pruritus questionnaire. Patients (N
= 145) suffering from uremic pruritus and receiving dialysis completed the questionnaire. Sixty
percent of respondents indicated that pruritus was aggravated during the night. Nervousness
(36%) and depression (8%) were reported related to the pruritus.

Thirty-three percent of

respondents described the pruritus as unbearable.
Summary of Findings Related to Wound Itch
Itch related to chronic wounds is not well described in the literature, but is found
clinically. The effects of wounds and itch on persons’ quality of life have been described, but
the significance of wound itch to persons with chronic wounds has not been explored. Wound
itch and its ramifications were explored in this study.
Preventing and Treating Wound Itch
As more is understood about wound itch, more appropriate interventions can be made to
manage wound itch. At the time this study was conducted, treatment options to prevent or
minimize itch were available. While all methods for preventing and treating itch might not be
appropriate for the various itchy wounds, options which might be considered are discussed.
Pharmacological Agents
Cooling Agents. Menthol, camphor, and icilin (a newly developed substance) activate
channels of the TRP (vanilloid) family and induce cold sensation which temporarily masks the
sensation of pruritus (Pogatzki-Zahn et al., 2008). Cold relieves pruritus by activating A-delta
fibers which inhibit C-fiber activity (Bromm, 2005). Icilin is 400-800 times more active in
bioassay endpoints than menthol and has proven to be effective against pruritus in a number of
cases (Kamei & Hossen, 2005). Cooling of an itchy area provides only short-term relief.
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Antidepressants. Several antidepressant drugs have proven to be effective antipruritics.
Doxepin has potent antihistamine H1 receptor properties (Greaves, 2005). Mirtazapine has
noradrenergic and serotonergic as well as H1-antihistaminic properties (Greaves, 2005).
Paroxetine and sertraline, selective serotonin reuptake inhibitors, target sodium- and calciumdependent transporters which inhibit uptake of neuromediators (i.e., serotonin) into presynaptic
cell bodies, so there is increased serotonin acting on postsynaptic receptors, resulting in
antipruritic effects (Pogatzki-Zahn et al., 2008).
Opioid and Cannibinoid Peptides.

Cannibinoids originate from epidermal

keratinocytes and neurons and have analgesic and antipruritic effects via cannabinoid receptors
(Ikoma et al., 2006).

Opioids also originate from neurons and keratinocytes and can be

antipruritic in the skin. Systemic opioids induce pruritus as previously discussed. Naloxone and
naltrexone, drugs that block opiate receptors, have been used to treat cholestatic pruritus
(Carlson, 2010; Greaves & Khalifa, 2004).
Chemotherapy. Oral chemotherapy (i.e., azathioprine and cyclosporine) and topical
immunosuppressants (i.e., tacrolimus and pimecrolimus) can be tried in cases of treatmentresistant pruritus (Pogatzki-Zahn et al., 2008; Yosipovitch et al., 2003). Photochemotherapy and
phototherapy (UVB) have been effective in some cases (Yosipovitch et al, 2003).
Anticonvulsants. Gabapentin may act by blocking post-synaptic calcium channels or
inhibiting neurotransmitter synthesis (Pogatzki-Zahn et al., 2008). Pregabalin acts similarly but
with more tolerable adverse effects.
Capsaicin. Capsaicin acts via vanilloid (TRPV1) receptors to induce burning pain or
pruritus (Stander et al., 2003). With topical application for several days, capsaicin desensitizes
nerve fibers for relief of itch (Pogatzki-Zahn et al., 2008).
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Zangrado. This red, blood-like sap is produced by cutting the bark of the sangre de
grado tree, which is found in the jungles of the upper Amazon (Miller, Rueter, Wallace, Sharkey,
& Bobrowski, 2004). The sap can be applied topically or taken orally for antipruritic therapy. It
appears to act via vanilloid receptor antagonism (Weisshaar et al., 2003) and has shown
unparalleled effectiveness against the itch of insect bites (Miller et al., 2004).
Refer to Table 1 for a summary of pharmacological measures that can be used against
pruritus.
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Table 1
Pharmacological Measures to Control Itch
Topical Agents
Measure
Cooling Agents
Menthol
Phenol
Camphor
Icilin
Calamine
Antihistamines
Topical steroids
Local anesthetics
Tacrolimus
Emollients
Capsaicin
Zangrado
Systemic Agents
Measure
Aspirin
Histamine (H1 and H2 receptor) antagonists
Doxepin
Amitriptyline
Mirtazapine
Ondasitron
Paroxetine
Sertraline
Fluvoxamine
Naloxone
Naltrexone
Nalmetene
Azathioprine
Cyclosporine
Gabapentin
Pregabalin
Glucocorticosteroids
1
Greaves, 2005
2
Pogatzki-Zahn et al., 2008
3
Heymann, 2006
4
Weisshaar et al., 2003
5
Sarvis, 2005
6
Yosipovitch et al, 2003
7
Yosipovitch & Hundley, 2004

Source
2,3,4,5,7
3,7
2,4,7
2
3
3,4,7
2,4,6,7
2,3,4,6,7
2,4,6,7
4,7
2,3,4,6,7
4,6,7

Source
6

2,3,4
2,3,4
2
2,3
3,4
2,3,4
2
2
2,4
2,4
2,4
6
2,4,6
2,6
2
4
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Non-pharmacological Measures for Treatment of Pruritus
Most of the non-pharmacological measures listed in Table 2 are familiar and rather selfexplanatory.

Chronic rubbing and scratching result in secondary skin lesions including

excoriations, lichenification and scars (Pogatzki-Zahn et al., 2008). Rubbing and scratching
should be avoided, especially where there is already a wound. Refer to Table 2 for nonpharmacological measures for controlling itch.
Table 2
Non-pharmacological Measures to Control Itch
Measure
Baths/showers in cool or lukewarm water
Hydrogel sheets
Low-pH cleansers and moisturizers
Use of humidifiers during dry, cold seasons
Lightweight, non-binding clothing
Avoidance of hot, spicy food and alcohol
Keeping fingernails short
Transcutaneous nerve stimulation
Cutaneous field stimulation
Broad-band ultraviolet B
Stress training
Social competence training
Relaxation techniques

Source
1,2
4
2,4
2
1,2
2
2
2,3
3
3
1
1
1

1

Weisshaar et al., 2003
Sarvis, 2005
3
Yosipovitch et al., 2003
4
Yosipovitch & Hundley, 2004
2

Transcutaneous electrical nerve stimulation.

Transcutaneous electrical nerve

stimulation (TENS) involves central inhibition of nerve conduction at the level of the spinal
cord. A stimulator generates alternating current through flat rubber electrode plates inducing
pressure and vibration. Low frequency TENS has been found to reduce itch significantly in
some cases (Wallengren, 2004).
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Broad-band Ultraviolet B Radiation Therapy. Radiation therapy has proven to be
effective in some cases (Greaves & Khalifa, 2004).
Cutaneous Field Stimulation. Cutaneous field stimulation is a newer technique, which
involves a flexible rubber electrode plate covered with 16 needle-like electrodes. When the plate
is pressed gently onto the skin, the electrode tips enter the epidermis and superficial layer of the
dermis. A constant current is delivered to each electrode causing prickling and a slight burning
pain so that itch is abolished for up to two hours after treatment (Wallengren, 2004).
Behavioral Programs.

Psychological co-morbidities frequently accompany chronic

pruritus so that behavioral programs including stress training, training in social competence and
relaxation techniques are indicated (Pogatzki-Zahn et al., 2008). A nursing program intended to
minimize itch and help the person cope with itch is described by van Os-Medendorp and
colleagues (2007). The program was developed in the Netherlands for an outpatient dermatology
department of a hospital.

The program consists of educational and cognitive behavioral

interventions including patient education, awareness training and habit reversal, relaxation
exercises and ongoing patient support.

A pretest-post-test design was used to examine the

effectiveness of the intervention. No changes were found in quality of life, but frequency and
intensity of itching and scratching, reduction in catastrophizing and helpless coping, and
reduction in skin-related psychosocial morbidity was found.
Summary Regarding Itch Management
Pharmacological and non-pharmacological options for itch management are available and
can be individualized based on wound-associated symptoms. As more is known about itch
physiology, advances in itch therapy can be made.
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Summary
Itch is a clinical problem impacting many individuals. In recent years itch has been
studied with some success due to scientific advances including PET scanning, fMRI. Even more
mysterious is the itch which persons with chronic wounds describe associated with, even in, their
wounds. Results of this study add to the understanding of wound itch in terms of manifestations,
quality of life, relationship to pain, and measures which are used to manage it. Findings of this
study add to nursing knowledge about the clinical presentation of wound-related itch and how it
can be managed.
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CHAPTER III
Theoretical Framework
This study of wound itch was based on Levine’s Conservation Model. In this chapter,
Levine’s Conservation Principles will be discussed as a conceptual framework from which the
Theory of Wound Itch was developed for the conduct of this study.
Conceptual Framework
Levine’s Conservation Model is applicable to the study of wound itch. The model is quite
simple, and the concepts are well-defined. The Conservation Principles are easily applied to
nursing practice, even to the study of wound itch. As wounds and itch are encountered in many
settings, the Conservation Model can be generalized to nurse-patient interactions in many
clinical settings. The model is empirically identifiable in that the concepts are scientifically
based (as wound itch is physiologically based) and clinically evident. Finally, the model is
important: it provides a time-tested “useful approach to bringing sound science to nursing
knowledge” (Levine, 1996, p.41).
Levine’s Conservation Model has ontological and epistemic claims consistent with the
reciprocal interaction world view, a post-positivist perspective. In this perspective, reality is not
just that which is observable, but is “multidimensional, context-dependent and relative”
(Fawcett, 2005, p.13). Both subjective sensory information as well as objective physical reality
is addressed (Jacox, Suppe, Campbell & Stashinko, 1999). Levine’s Conservation Model is
consistent with the Systems Category of Knowledge which has its origins in biology and physics.
The human being is an open system, interacting with the environment “with fluidity and change”
(Levine, 1969b, p.94).
Philosophical Assumptions
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The following are philosophical assumptions in Levine’s Conservation Model:
1. Reality is multidimensional with subjective and objective components (Fawcett, 2005).
2. A person is an open system in constant interaction with the environment (Levine, 1969a).
3. A person is dependent in a nursing relationship (Levine, 1989b, p. 128).
4. The goals of nursing are to promote life and alleviate suffering (Levine, 1989a).
Values Supported by Levine’s Conservation Model
Levine’s Conservation Model is based on values consistent with the values of the author
and a description of nursing which accurately defines its scope and purpose. First, Levine
(1989a) values the sanctity of life as stated:
All efforts of the healing sciences are founded on the holiness and wholeness of
the human being, and the special injunction this places upon the caregiver to bring
dignity and compassion to the tasks of caring for another person . . . The sanctity
of life . . . is the essence of the respectful relationship that one person must have
for another. It is never more important than when a nurse-patient dyad is created
whereby one individual enters dependency, willing or not, and places his trust in
another person (p.125).
These words provide a beautiful statement of the essence of nursing. “The goal of all nursing
care should be to promote wholeness, realizing that for every individual that requires a unique
and separate cluster of activities” (Levine, 1971, p. 258).
The second value addressed by Levine is the “absolute moral duty to prevent or alleviate
suffering” (Levine, 1989a, p.126). Levine uses the term “patient “as the recipient of nursing care
as the word “patient “ has its core in the Latin word for “suffering” (1989a). Levine contends:
“It is the moral duty of the nurse to confront the suffering individual and bring all the skills of
the hand, heart, and mind to alleviate it” (Levine, 1989a, p. 126). This value particularly
addresses the obligation nurses have to alleviate suffering. Wound itch causes suffering.
Levine recognizes the contributions of other, adjunctive disciplines to nursing and
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appreciates the “rich reservoir of knowledge in the many disciplines that contribute to
understanding of human life” (1995, p. 13).

A great emphasis is placed on physiologic

functioning, and Levine depicts nursing working alongside medicine and other disciplines to
meet patients’ needs. This collaborative effort is necessary to address a multidimensional
problem such as wound itch.
Concepts and Propositions of Levine’s Conceptual Framework
Levine’s model is based on the premise that human beings are “organismic”, a
combination of related, even redundant, systems that functions as one, integrated whole (Levine,
1969a, p.10). According to Levine, the expression of “wholeness” can “only be used if it can be
converted to manageable parts” (1989b, p. 326). Health means whole (Levine, 1971). Illness
occurs when positive feedback within the system runs without the usual controls that restore
balance (Levine, 1973). Levine contends that the person cannot be studied separated from the
environment which is the “predicament of time and place” (1989b, p. 326). Environment is both
internal and external (Levine, 1973).

The internal environment is described as having

homeostasis (equilibrium, a stable state) and homeorhesis (a stabilized flow) (Levine, 1971, p.7).
The external environment is at once perceptual (sensed), operational (not sensed, yet present and
potentially threatening), and conceptual (interpreted based on beliefs and values). “Nursing is a
human interaction. It is a discipline rooted in the organic dependency of the individual human
being on his relationships with other human beings” (Levine, 1969a, p.1).
Conceptual Model Concepts
Five concepts from Levine’s Conservation Model were used for development of the
middle-range Theory of Wound Itch:
conservation, and integrity.

environment, organismic response, adaptation,
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Environment.

As described above, the internal environment has two dimensions:

homeostasis and homeorhesis. Homeostasis is defined as the “remarkable equilibrium that is
maintained in the internal environment in the face of constant change” (Levine, 1969a, p.7).
Homeorhesis is defined as a stabilized flow within a person, which permits the body to sustain its
well-being within the vast changes that encroach upon it from the environment (1973, p.7). The
external environment has three dimensions: perceptual environment, operational environment,
and conceptual environment. The perceptual environment is defined as that portion of the
environment to which the individual responds with his sense organs (1973, p.12).

The

operational environment is defined as that portion of the environment, which is not directly
perceived by the individual, including radiation, microorganisms and pollutants, but which is of
vital concern to the individual because of its potential danger (1989b, p. 326). The conceptual
environment is defined as the “exchange of language, the ability to think and experience
emotion . . . value systems, religious beliefs, ethnic and cultural traditions, and the individual
psychological patterns that come from life experiences” (1973, p.12). “The nurse participates
actively in every patient’s environment” (1969a, p.10). Levine (1973) further explains:
Change is the essence of life . . . and adaptation is the method of change. The
Organism retains its integrity in both the internal and external environment
through its adaptive capability. Adaptation is the process of change whereby the
individual retains his integrity within the realities of his environment” ( pp. 10-11).
Organismic Response.

Organismic responses encompass four “physiologically

predetermined” dimensions (Levine, 1969, p. 95).

The four levels are:

Fight or Flight

Response, Inflammatory-Immune Response, Stress Response, and Perceptual Awareness. The
Fight or Flight Response is the most primitive level of organismic response and is defined as an
adrenocortical-sympathetic reaction that is an instantaneous response to a real or imagined
threat” (Levine, 1973). The Inflammatory-Immune Response is the second level of organismic
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response and is defined as a “systematized concentration of available energy directed at the
exclusion and removal an intruding irritant or pathogen”(Levine, 1969b, p. 95). The Stress
Response is the third level of organismic response and is defined as a “long-term organismic
reaction to the exigencies of life and the sum total of the individual’s life experiences” (1969b, p.
95). The Perceptual Awareness Response is the fourth level of organismic response and is
defined as “all the experiences of life . . . mediated through tissues of the living individual”
(1969b, p. 96). The Perceptual Awareness Response encompasses five subdivisions, including
the: (a) Basic Orienting System, (b) Visual System, (c) Auditory System, (d) Haptic System, and
(e) Taste-Smell System.

The Basic Orienting System provides general orientation in the

environment. The Visual System enables the individual to see. The Auditory System enables the
individual to hear. The Haptic System is especially relevant to wound itch and is described as
responding to touch with information “received by the skin surfaces and body orifices as well as
the joints and muscles and their associated tendons. It enables the individual to explore his
environment, and establishes contact with the material nature of his environment” (1969b, p. 97).
The Taste-Smell System provides information about chemical stimuli and facilitates safe
nourishment.
Adaptation. Adaptation is defined as “the process of change whereby an individual
retains his integrity within the realities of his environments” (Levine, 1969a, p. 9-10).
“Change is characteristic of life, and adaptation is the method of change. The
organism retains its integrity in both the internal and external environment
through its adaptive capability” (1969a, p. 9).
Adaptation has dimensions of historicity, specificity, and redundancy.
Integrity. Integrity is defined as the “unique oneness of the whole person” (Levine,
1991, p. 3). The promotion of integrity is the goal of nursing (Levine, 1973). Conservation of
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energy, structural integrity, personal integrity and social integrity to promote the unique oneness
of the person are the basis of nursing interventions.
Conservation.

Conservation is defined as “the guardian activity that defends and

protects the [wholeness, which is] the universal target of selfhood” (Levine, 1991, p.4).
Conservation describes the way complex systems are able to continue to function, even when
severely challenged . . . This work is accomplished in the most economical way possible” (1990,
p. 192). Levine’s (1969a) Conservation Principles encompass four dimensions: (a) Principle of
Conservation of Energy, (b) Principle of Conservation of Structural Integrity, (c) Principle of
Conservation of Personal Integrity, and (d) Principle of Conservation of Social Integrity. The
Principle of Conservation of Energy refers to balancing energy output and energy input to avoid
excessive fatigue, that is, adequate rest, nutrition, and exercise. The Principle of Conservation of
Structural Integrity refers to maintaining or restoring the structure of the body by preventing
physical breakdown and restoring healing. The Principle of Conservation of Personal Integrity
refers to the maintenance or restoration of the person’s sense of identity, self-worth, and
acknowledgement of uniqueness. The Principle of Conservation of Social Integrity refers to the
acknowledgement of the patient as a social being.
Principles of Conservation
The nursing process is one of “conservation . . . keeping together” (1967, p. 46).
According to Levine (1989b), conservation should be the major guideline of all nursing
intervention. The problem of wound itch can be approached with each of the Conservation
Principles.
The Principle of Conservation of Patient Energy and Wound Itch. Conservation of
energy is essential to the patient with a wound because the body requires an energy expenditure
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which is greater than usual during the healing process (Neswick, 1997). The problem of wound
itch compounds the issue of conserving patient energy in that it: (a) causes the urge to act by
scratching or rubbing and (b) causes a discomfort which can preclude sleep or rest as needed for
healing and recovery. Levine described the body of the very sick person “in its wisdom,
withdrawing into itself, spending its resources on the process of healing” (1989b, p. 332).
Levine (1967) recognized that any insult to physiological function, even as minor as an infected
toenail, alters the metabolism of the entire body if accompanied by an elevated temperature. In
consideration of this principle, the nurse would assess for complaints of discomfort related to
wound itch. The nurse would also look for energy-expending behaviors such as scratching,
rubbing, and general restlessness. Nutritional status including protein and caloric intake would
also be assessed.

The nurse would intervene with pharmacological as well as non-

pharmacological approaches to conserve energy by providing measures for comfort.
The Principle of Conservation of Structural Integrity and Wound Itch. Individual
patients are “continuous with the rest of the natural world” in a relationship, which is
characterized by an incessant and unrelieved exchange, which is absolutely necessary for
survival” (Levine, 1971, p. 256). A person’s internal and external environments are in constant
interaction with each other. The internal environment is “captured within the integument of the
human body” (Levine, 1973, p. 7). The perceptual aspect of the environment is divided into the
basic orienting system, the auditory system, the haptic system, the taste-smell system and the
visual system (Levine, 1969b). The haptic system responds to touch and relies on skin surfaces.
Here the significance of the skin (integument) is clearly specified related to structural integrity.
Nurses are directed to focus on the response of the entire organism and the adaptive pattern. In
consideration of this principle, the nurse would make careful assessments of wounds, including
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any indication of trauma or irritation related to rubbing or scratching. Nursing interventions
would be those that conserve tissue integrity or promote healing of wounded tissue (i.e.,
pressure-relief measures, dressing changes). Rubbing and scratching in response to wound itch
would likely aggravate wounds, so interventions to manage wound itch would be sought.
The Principle of Conservation of Personal Integrity and Wound Itch. Every person
needs to be identified as a unique individual (Levine, 1973). Personal integrity is maintained by
guarding patient privacy and allowing each patient to make decisions. Related to wound itch,
nurses are directed to maintain privacy in discussions about wound itch and during wound
assessments. In consideration of this principle, nurses would assess the patient’s values and
preferences related to wound care and wound itch management. Patients should be given
options, whenever possible, about the timing of wound assessments, timing of wound-related
discussions, and alternatives to try for the management of wound itch. Information shared by the
patient should be kept confidential, even as a component of the plan of care, if possible, to
protect the integrity of the person.
The Principle of Conservation of Social Integrity and Wound Itch. Selfhood needs
definition beyond the individual to the identity of the person “in a family, a community, a
cultural heritage, a religious belief, a socioeconomic slot, an educational background, a
vocational choice” (Levine, 1989b, p. 335). Wound itch and related behaviors may have aspects
which are not socially acceptable. Wounds may be unsightly, draining, and foul smelling. Itch
may connote the socially undesirable conditions of uncleanliness and infestation. Scabies is, in
fact, the third definition of itch in the Oxford English Dictionary (Hawkins and Allen, 1991, p.
755). Accordingly, the nurse must recognize the social implications of wounds and wound itch
for each patient and intervene to help the patient manage the wound and its undesirable
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characteristics.
Relational Propositions of Levine’s Theory
The first relational proposition describes an association of environment to organismic
response: “A person responds to changes that encroach upon it from the environment with an
organismic response” (Levine, 1973, p. 7). The second relational statement links organismic
response to adaptation: The capacity of the organismic response to adequately respond to the
environment is determined by adaptation that is available to the organism (1969b, p. 95). Two
relational propositions describe a reciprocal relationship between adaptation and conservation:
“Integration is defended by adaptations that create the condition of conservation” (1989b, p.
330). Adaptation occurs when conservation measures effect change whereby the individual
retains integrity within the realities of the environment. A fifth relational proposition links
conservation with integrity: Conservation defends the wholeness of living systems by ensuring
their ability to confront change appropriately and retain their unique identity (Levine, 1990, p.
192). These statements were difficult to find in Levine’s works and the relationships are rather
imbedded in the statements. There has been much thought over the location of adaptation as an
antecedent to, or consequence of, conservation.
The Theory of Wound Itch
Assumptions of the Theory
Assumptions of the Theory of Wound Itch are those of Levine’s Conservation Model as
listed previously with several additional assumptions:
1. Wound itch is a subjective phenomenon, which can be constant or fleeting, annoying or
deeply disturbing.
2. Wound itch is commonly experienced by persons with disruption in skin integrity.
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3. Itch is a negative sensation.
4. Nurses are in a position to intervene for persons with wound itch.
Concepts and Definitional Propositions
Wound Itch. A wound is defined as “a disruption of the integrity and function of tissues
in the body” (Baranoski & Ayello, 2008). Wounds commonly found in wound care practice
include vascular (related to arterial disease or venous insufficiency), neuropathic, traumatic,
pressure-related wounds and wounds of mixed etiology, as defined in Chapter I. An organismic
response at the conceptual level is represented by wound itch at the theoretical level. Wound itch
has fight/flight, inflammatory-immune (physiological), stress (psychological), and perceptual
awareness (sensation) dimensions.
Disruption of Skin Integrity. Disruption is defined by the Oxford-English Dictionary
Online (2009) as “dissolution of continuity.”

Skin is defined as “integument.” Integrity is

“material wholeness, completeness, entirety; unimpaired or uncorrupted condition.” Disruption
of skin integrity is defined as dissolution of completeness of the integument. [Disruption of] the
environment at the conceptual level is represented by disruption of skin integrity at the
theoretical level. Operationally, disruption of the environment is the wound.
Protection. Protection is defined as “shelter, defense, preservation from harm, danger,
damage: care” (Oxford-English Dictionary Online, 2009). For the theory, protection is measures
taken by the individual who has disruption of skin integrity or by the nurse to influence
regulation. Conservation at the conceptual level is represented by protection at the theoretical
level. Operationally, protection is all that is done to manage wound itch.
Regulation. Regulation is defined as “the property whereby a living organism can adapt
the form of its body to accommodate for changes made or damage done to it, and whereby, in the
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normal course of development, the nature and growth of the various parts are so inter-related as
to produce an integrated whole” (Oxford-English Dictionary Online, 2009). Adaptation at the
conceptual level is represented by regulation at the theoretical level. Adaptation can be positive
(effective) or negative (ineffective), as regulation can be positive (e.g. tissue growth) or negative
(e.g. eschar development or further deterioration of the wound).

At the operational level,

adaptation is the physiological response to the wound itch, conscious or unconscious.
Continuity. Continuity is defined as a “state or quality of being uninterrupted” (OxfordEnglish Dictionary Online, 2009). Integrity at the conceptual level is represented by continuity
at the theoretical level. Operationally, quality of life is an indicator of continuity.

Figure 1. Concepts and relationships of Levine’s Conservation Model and the Theory of Wound
Itch as substructed from Levine’s conceptual framework.
Relational Propositions of the Theory of Wound Itch
Refer to Figure 1 for a depiction of the relationships between the concepts of the theory.
There is a reciprocal relationship between disruption in skin integrity and wound itch. The itchscratch cycle is described in which itch elicits a scratch response (Stander et al., 2003;
Yosipovitch & Hundley, 2004). The scratching causes inflammation and further stimulation of
nerve fibers, which results in the sensation of itch. The sensation of itch then prompts further
scratching or rubbing. Regulation is associated with wound itch as the systems of the person
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with wound itch adjust in response to the itch.

A reciprocal relationship exists between

regulation and protection as protective measures are taken by the person and, as indicated, by the
nurse, to respond with most economical means when regulation is ineffective. Those measures
can, in return, impact the sensation of itch (i.e., acetic acid solution as a pruritogen). Protection
is associated with continuity as disruption in skin integrity resolves when effective protective
measures are taken to prevent further disruption. A model of the Theory of Wound Itch is
depicted in Figure 2.
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Figure 2. Model of the Theory of Wound Itch. The model illustrates concepts and relationships
(arrows) of the Theory of Wound Itch.
Operationalizing the Theory of Wound Itch
As previously described, a disruption of skin integrity operationally was the wound.
Wounds were assessed and wound characteristics documented according to components of the
Bates-Jensen Wound Assessment Tool (Bolton et al., 2004). Wound itch, the sensation and how
it is perceived was captured on the Paul-Pieper Itching Questionnaire and the Characteristics of
Itch Questionnaire (Dawn et al., 2008). The Brief Pain Inventory was used to further define
wound sensations. Regulation was indicated by response to wound itch: it was represented

48

operationally with the Paul-Pieper Itching Questionnaire and the Characteristics of Itch
Questionnaire. Protection, measures taken to manage wound itch, were captured on the PaulPieper Itching Questionnaire.

Continuity, was captured with the Characteristics of Itch

Questionnaire and the RAND-12 (Hays et al., 1998). These instruments will be further discussed
in Chapter 4.
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CHAPTER IV
Method
Design
In this chapter, the design, setting, sample, data collection procedures, instruments, and
data analysis for this study are described. The study used an observational design, as that is
appropriate for the state of the science; although itch is a familiar phenomenon, little is known
about itch as it occurs with chronic wounds. The research questions were: (a) What is the
frequency, timing, duration, and intensity of itch related to chronic wounds? (b) What is the
relationship between wound characteristics and itch? (c) What treatments do participants use to
manage wound itch? (d) How does wound itch affect quality of life for these participants? and
(e) What is the relationship between wound itch and pain?
Setting
The study was conducted at the Beaumont Wound Care Center, which is affiliated with
William Beaumont Hospital in Royal Oak, Michigan. William Beaumont Hospital, Royal Oak,
is a large teaching institution located in Southeastern Michigan. The primary investigator is a
plastic surgery/wound care nurse practitioner for inpatients at the hospital and has a good
relationship with the physicians and staff of the wound care center. The wound care center is
staffed with plastic surgeons, peripheral vascular surgeons, general surgeons, podiatrists, a nurse
practitioner, and staff nurses. The wound care center manages approximately 800 patient visits
per month with 420 charts open at any time. The wounds of patients followed at the wound care
center are approximately 30% vascular, 30% neuropathic, 30% pressure-related, and 10% related
to other causes.
Plans were also made to conduct the study at the private office of a podiatrist on staff at
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the Beaumont Wound Care Center, as the podiatrist offered his office as an additional site. The
podiatrist's private office is located approximately five miles north of the hospital-affiliated
wound care center. Wound of patients followed at the podiatrist's office include vascular,
neuropathic, pressure-related and other types, similar to those found at the wound care center.
Data collection at the podiatrist’s office was not included as the sample was entirely recruited at
the wound care center.
Sample
The sample included 200 outpatients with wounds who were visiting the hospitalaffiliated wound care center for wound treatment. Consecutive sampling involved recruiting
persons two to three days each week who were visiting the wound care center those days. Since
the wound care center has 420 charts open at any time, obtaining 200 participants was possible.
A podiatrist on staff at the wound care center offered that his private office be used as a data
collection site to expedite the data collection process. Patients were screened until a total of 200
participants were recruited. The screening information was retained for comparison to interview
responses. The number of patients who needed to be screened depended on the actual prevalence
of wound itch. It became apparent once 100 participants had been interviewed that
approximately one fourth of persons being seen at the wound care center had wound-related itch.
Wound characteristics were assumed to have a disproportionate n. This disproportionate n
reduced power relative to the same n divided equally. Power and sample size were computed for
a two-sample t-test power analysis. A target sample size of 225 allowed for a power of .86 with
a medium effect size and alpha set at .05. A refusal rate of approximately 5% was expected
related to patient unwillingness to discuss negative sensations related to wounds, so a resulting
sample size of 200 was sought. Children, persons aged less than 18 years as distinguished in
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Michigan (S.241, 2004), were excluded as the interview questionnaires were designed for adults.
Pregnant women were not likely to be followed at the wound care center, and pregnancy
predisposes a woman to a multitude of pregnancy-related pruritic conditions (Shornick, 1994), so
pregnancy was an exclusion criterion. Inclusion criteria allowed for patients: (a) with open
wounds including vascular (arterial or venous), neuropathic, traumatic or pressure-related
wounds (as determined by each patient’s medical history and/or wound presentation), (b) age 18
years and older, and (c) able to understand and speak English. Exclusion criteria included: (a)
pregnancy, (b) closed surgical wounds, (c) a rash in the area of the wound, or (d) a pruritic skin
condition involving more than 20% of body surface area. The participant was not excluded if
sensation in the area could not be confirmed, as itch could potentially be perceived without
sensation in the area of the wound according to an understanding of a central, in addition to
peripheral, origin of itch as previously described. Patients with surgical wounds and extensive
burns are not typically followed at the wound care center.
Data Collection Procedures
All patients who met inclusion criteria and were followed at the wound care center were
considered for inclusion in the study. Data were collected by the primary investigator who
introduced the study to patients and determined eligibility. The primary investigator approached
persons who were waiting in private rooms at the wound care center to introduce the study to
each person. Persons willing to participate in the study were asked the screening questions
(Appendix A) to determine eligibility. Once eligibility was determined the primary investigator
reviewed the content of the information sheet (Appendix B) with the patient. Each person
willing to participate was assessed and interviewed in a private room. All questionnaires were
read to the participants for response. Each interview took 20 to 60 minutes to complete,
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depending on number of symptoms and speed of response. The medical record was reviewed
during the visit day for diagnoses, medical history, medications, and allergies.
One wound for each patient was assessed for wound characteristics and itch: either the
largest wound with associated itch or the largest wound when itch was not described.
Photographs of each assessed wound were taken as is routine at the wound care center.
Photographs of each wound were obtained for purposes of the researcher’s recollection, use for
publication, and inclusion in presentations. A disposable Semmes-Weinstein 5.07 (10 gram)
monofilament was used to evaluate sensation in the area of the wound. Wound assessments were
conducted concurrently with the wound care center staff to avoid unnecessary discomfort
associated with dressing changes and wound assessments. This protocol followed standard
procedure, so the risk of injury was small. A log was kept at the wound care center, which
included each participant’s name and the date of the interview, so that interviews were not
duplicated.
Participants were each given $10 at completion of the interview and wound assessment in
appreciation of their time and cooperation. When payment was received the participant initialed
a form (Appendix C) concerning receipt of the information sheet and receipt of the compensation
money. The form included the participant’s name, the amount of payment, the data researcher’s
signature, and the date. This form was added to each participant’s chart. No monetary award
was given to participants who did not complete the interview or assessment.
Data collection was reviewed after the first five participants had completed the pilot
phase of the study. The data collection process was reviewed and evaluated. Feedback on the
process was obtained from the wound care center, and the research process continued.
Instruments
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Bates-Jensen Wound Assessment Tool (BWAT).

The Bates-Jensen Wound

Assessment Tool was developed cooperatively by Bates-Jensen with Bolton and colleagues
(2004) for documentation of wound assessments.

The instrument was formerly known as the

Pressure Sore Status Tool (PSST) with a content validity index of .91 and a mean inter-rater
reliability coefficient of .915 among enterostomal therapy nurses, and .78 among practitioners
(Bates-Jensen, Vredevoe, & Brecht, 1992; Bates-Jensen & McNees, 1995). The PSST was
subsequently modified to accommodate all types of wounds (Bolton et al., 2004). Cronbach’s
alpha (internal consistency reliability coefficient) for this instrument is .96 (Bolton et al., 2004).
It was used to document wound characteristics (such as size, surrounding tissue, exudate,
presence of necrotic or granulation tissue, and epithelialization) as obtained during clinical
wound assessments.

Sensation around the wound and current treatment regime were

documented additionally.

This BWAT empirically captured disruption of skin integrity as

described in the Theory of Wound Itch. The instrument contains two items for documentation of
wound location and shape, 13 numbered assessment items, and a “Wound Status Continuum.”
The descriptors for each assessment item are scored and ranked on a modified Likert scale (1
being the healthiest attribute of the characteristic and 5 being the least healthy attribute of the
assessment item). A higher score indicates a more severe wound status. The 13 assessment
items scores are added to determine a numerical indicator of wound health or degeneration
(Lyder & Ayello, 2010). Two items were added to the BWAT: an item for recording sensation
in the area of the wound and an item for recording current dressing. Permission to use the
instrument was obtained from Dr. Bates-Jensen and Dr. Bolton. See Appendix D for the BWAT.
Medical (10 gram) Monofilament.

A disposable 10-gram monofilament (Medical

Monofilament Manufacturing, Plymouth, MA) was used, following the procedure as described
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by Driver, Landowski, and Madsen (2007), to determine sensation in the area of the wound.
The American Diabetes Association recommends annual screening for diabetic neuropathy using
the10-gram monofilament (Boulton et al., 2005) with intra-rater reliability established for
assessment of cutaneous sensitivity in feet (Collins et al., 2010). The monofilament is a handheld device with a short filament (fishing line) attached to a paper handle. The instrument has
been standardized to deliver a 10-gram force to an area of the skin. Before assessment of
sensation, the procedure was explained to the participant. According to the procedure, the
participant was positioned for comfort and so that the area of the wound was accessible. The
monofilament was first used on the participant’s hand so that the participant knew what to
expect. The participant was instructed to say “yes” when the monofilament was felt against the
skin. The monofilament was applied perpendicular to the surface of the skin, within two
centimeters of the wound margin, avoiding callus or open skin, and with enough force to cause
the filament to bend. The monofilament was applied to a maximum of three areas, and only until
sensation was confirmed, totaling approximately one to two seconds to approach, contact, and
release each time. Sensation around the wound was recorded as a numbered response on the
BWAT: 3 if sensation was felt in at all three areas, 2 if sensation was felt in two areas, 1 if
sensation was felt in only one area, and 0 if sensation was not confirmed in any area.
Paul-Pieper Itching Questionnaire. The Paul-Pieper Itching Questionnaire (PPIQ), an
instrument developed specifically for the evaluation of wound itch and persons’ treatment of it,
was developed by Dr. Barbara Pieper and the primary investigator of this study. The instrument
was added to the data collection portion of Dr. Pieper’s study, which was funded by the National
Institute of Health, entitled “Effect of Drug Use on the Legs: Chronic Venous Insufficiency,
Mobility and Pain.” The larger study explored chronic venous disease, mobility and pain in
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persons in methadone treatment. The Paul-Pieper Itching Questionnaire is a compilation of
questions based on itch literature and clinical experience. It consists of 15 interview questions:
three rating scales and 12 multiple response items concerning itching around the wound, itching
on the wound, timing of wound itch, and treatments used for wound itch. This instrument
empirically captures wound itch, regulation, and protection as described in the Theory of Wound
Itch. Items are nominal so the responses were hand scored. Reliability of this instrument could
not be calculated because it is a survey versus a summative rating scale. Based on use in the
previous study (Paul et al., 2010), options were deleted related to no itch, and an early end-point
was added for cases with no itch. Several options for treatment of itch were added as well as an
item to determine what aggravates wound itch.

See the Paul-Pieper Itch Questionnaire in

Appendix E.
Characteristics of Itch Questionnaire. The Characteristics of Itch Questionnaire was
developed by Dr. Gil Yosipovitch and colleagues, based on the Eppendorf Itch Questionnaire
(Dawn et al., 2008). The Eppendorf Itch Questionnaire was developed based on the short form
of the McGill Pain Questionnaire (Darsow et al., 2001).

The Characteristics of Itch

Questionnaire includes 10 demographic items, six items regarding itch history, 45 itch
descriptors, an item regarding timing of itch, and an item about scratching. Wound-related itch
is rated as 0 for not at all, 1 for to a minimal extent or rarely, 2 for to a mild extent or maybe
sometimes, 3 for to a moderate extent or occasionally, and 4 for to a great extent or very much.
Completion of the instrument took 15 to 20 minutes. This instrument empirically captured
wound itch, regulation, and protection as described in the Theory of Wound Itch. The items are
nominal and ordinal. Test-retest reliability is .8. Scoring was done by hand. See Appendix F
for the Characteristics of Itch Questionnaire. As items are replicated between the Paul-Pieper
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Itching Questionnaire and the Characteristics of Itch Questionnaire, the two instruments were
divided and reorganized for a more logical sequence of questions for the interview.

See

Appendix I for the complete Wound Itch Interview Tool.
RAND-12 Health Status Inventory. The RAND-12 Health Status Inventory (RAND12) is the short form of the RAND-36, which was developed to measure general health status
(Hays et al., 1998).

The RAND-12 consists of the same questions as the widely used Short

Form 12 (SF-12), but with RAND scoring factor weights have been calculated with oblique
rotation, so physical health and mental health components are allowed to correlate (Windsor,
Rodgers, Butterworth, Anstey, & Jorm, 2006).

The RAND-12 has demonstrated greater

sensitivity than the SF-12 in persons with more moderate symptom severity (Lee, Browne, &
Villanueva, 2008). Eight health constructs are covered: physical functioning (two items), role
limitations caused by physical health problems (two items), pain (one item), general health
perceptions (one item), emotional well-being (two items), role limitations caused by emotional
problems (two items), social functioning (one item), and energy/fatigue (one item) (Hays et al.,
1998). Two summary scores can be calculated (one for physical health and one for mental
health) as well as a composite health score. Scores can be checked against established t-scores
(Hays et al., 1998). Internal consistency reliability coefficients for the individual scales of the
RAND-36 are reported with description of the RAND-12 as ranging from .71 to .90, with
coefficients for the composite scales higher at .88 to .96 (Frederick, 2001). The instrument took
only two to three minutes to complete. Continuity, as described in the Theory of Wound Itch, is
empirically indicated by this instrument. This instrument is in the public domain and was used
with permission granted by The Psychological Corporation. See Appendix G for the RAND-12.
Brief Pain Inventory. The Brief Pain Inventory (BPI) was originally developed for
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cancer patients to measure intensity of pain and pain interference (Daut, Cleeland, & Flanery,
1983). Validity of the BPI for assessment of non-cancer pain has been established (Keller, Bann,
Dodd, Schein, Mendoza, & Cleeland, 2004). The instrument has demonstrated a coefficient
alpha above .7 and acceptable test-retest correlations (Statistics Solutions, 2010). The BPI
consists of 15 items and addresses pain location, chronicity of pain, severity of pain, pain
interference, and amount of relief. Scores for worst pain, least pain, average pain, and pain now
are given along a 0-to-10 continuum, with high scores indicating more severe pain. A Pain
Severity Score can be obtained from the mean of the scores for worst, least, and average pain
(Keller et al., 2004). Scores for the amount of pain interference with general activity, mood,
walking ability, normal work, relations with other people, sleep, and enjoyment of life over the
past 24 hours are given along a 0-to-10 scale, with high scores indicating more interference. A
Pain Interference Score can be obtained by averaging the scores for pain interference (Keller et
al., 2004). The instrument took approximately five to ten minutes to complete. The BPI was
included to allow participants to discuss their pain and to distinguish itch from pain.
Descriptors of pain as included on some versions of the BPI overlapped with descriptors in the
Characteristics of Itch Questionnaire. Participants rated descriptors for pain as included in the
Characteristics of Itch Questionnaire and as taken from the McGill Pain Questionnaire to allow
discussion of painful wound sensations and to allow further comparison of itch to pain. The
Brief Pain Inventory is in the public domain. See Appendix H for the Brief Pain Inventory.
The instruments were included in entirety in the interview but were re-arranged for
interview flow and clarity. The resulting Wound Itch Interview Tool is included in Appendix I.
Medical Record Data Collection Tool. Participants’ medical records were accessed to
obtain five categories of information including wound type/diagnosis, dermatologic diagnoses,
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medical diagnoses, current medications, and allergies. The dermatologic diagnosis and current
medications are items on the Characteristics of Itch Questionnaire. Wound type/diagnosis,
medical diagnoses, and allergies were added as information that is likely pertinent to experiences
of itch. The Medical Record Data Collection Tool is included in Appendix J.
Ethical Considerations
The primary investigator completed all Collaborative Institutional Training Initiative
(CITI) modules for researchers prior to collecting data. Approval to conduct this study was
obtained from Beaumont Hospital’s Commission of Nursing Scholarship and Research (see
Appendix K) and Beaumont’s Human Investigation Committee (see Appendix L) and Wayne
State University’s HIC (see Appendix M). An amendment to the research protocol to include the
office of a podiatrist was also approved by both institutions.
Data were collected only once each participant had agreed to participate in the study and
had received the information sheet about the research study. Every effort was taken to maintain
participant privacy and confidentiality of information. The interviews and wound assessments
were conducted in private rooms of the wound care center. Participants’ wounds were assessed,
which may have caused discomfort. Wound assessments were done concurrently with the
wound care physician or nurse practitioner to avoid unnecessary discomfort associated with
dressing changes and wound assessments. Participants were asked to recall and discuss the
personal and potentially distressing phenomena of wound itch and pain. Analgesics or antipruritics were offered as indicated. Participants may have felt obligated to participate in the
study, as the wound care center staff encouraged participation. All participants were given the
option of discontinuing participation in the study at any time during the interviews or wound
assessments.
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A paper list of participants and their coded identifiers were kept in a locked cabinet in the
primary investigator’s office, which is located in the hospital with which the wound care center
is affiliated. Only the primary investigator had access to the list. A booklet of participants’
names without coded identifiers was kept at the wound care center.

Only the primary

investigator and wound care center staff had access to the booklet, to keep track of study
participants in order to prevent duplication of data. Photographs were taken in such a manner
that participants cannot be identified in them. Completed data collection forms continue to be
stored in a second locked cabinet in the primary investigator’s office and have been coded so as
not to contain identifying information.
Data Analysis
Data were analyzed using SPSS (Version19) software.

As a doctoral student, the

primary investigator received statistical assistance from the Center for Health Research, College
of Nursing, Wayne State University. Descriptive statistics were used, including X2, t-tests, and
other exploratory procedures. The primary outcome measure, wound itch, was measured with
five questions on the Paul-Pieper Itching Questionnaire (question numbers 9 – 13). Two
questions measured severity of itch. Wound itch was measured dichotomously (yes/no) with one
question. Two questions were used to determine if itch was sensed on the wound versus near the
wound. Responses of those two questions were combined and recorded as wound-related itch.
The distribution of itch was dichotomous as wound-related itch was either present or not present.
Descriptive statistics were used to answer the research question concerning the
frequency, timing, duration and intensity of itch related to chronic wounds and the research
question concerning treatments used by participants manage wound itch. Descriptive statistics,
including frequencies, ranges, and means, were used to summarize wound itch frequency,
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timing, duration, and intensity as well as information about therapeutic measures.
Characteristics of wounds were assessed with the Bates-Jensen Wound Assessment Tool,
which assesses 13 wound characteristics with ordinal response scales coded one through five,
with higher scores indicating more serious wound status. The association of each characteristic
to wound itch was evaluated. Four types of analyses were performed: (a) Independent group ttests were used to compare mean ratings across itch and non-itch groups. This analysis treats the
ordinal categories numerically and is a sensitive test when the probability of itch is linearly
related to wound characteristics. Student’s t-tests column proportions were reviewed to further
explore significant categories within wound characteristics, but did not provide meaningful
results. The independent group t-test is comparable to the point-biserial correlation between itch
and the wound characteristic score, the ordinary least squares regression of itch on the wound
characteristic, and the linear by linear association in the chi-square results for the SPSS
Crosstabs procedure. (b) X2 tests of association were used to identify significant associations
between itch and wound characteristics. The X2 test can detect associations that are not linear.
(c) Bar plots were examined to determine the possibility of nonlinear functional relationships
that would not be identified with either t-test or X2. (d) Logistic regression analysis was used to
test nonlinear functional relationships when descriptive plots showed nonlinearity in column
proportions (e.g., when the conditional probability of itch, given the level of wound
characteristic, could be described as a trend that first increased, then decreased).
The logistic regression used four pre-defined contrasts. Each contrast compared the first
wound characteristic category with one of the succeeding categories. Binary logistic regression
was used to analyze wound itch associated each subsequent category against the lowest (best)
category for each wound characteristic on the Bates-Jensen Wound Assessment Tool. Logistic
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regression was also used to provide 95% confidence intervals for category proportions.
Spearman’s rank order correlations and point-biserial correlations were calculated and
compared to determine the magnitude of linearity of each Bates-Jensen wound characteristic.
Spearman’s rank order correlation is a non-parametric index in which all data are first ranked for
each of the two variables, and the ranked data are subsequently correlated. The point-biserial
correlation coefficient is appropriate when one measure is on an interval scale (Bates-Jensen
wound characteristic) and the other measure is dichotomous (wound itch present or not present).
The research question concerning the effect of wound itch on quality of life was analyzed
by using independent samples t-tests to compare responses of participants who reported woundrelated itch with responses of participants who did not report itching. Independent samples ttests of the Physical Component Scores as well as the Mental Component Scores for participants
with and without wound-related itch were also performed.
Correlations between responses about wound itch and responses about pain were
calculated to answer the research question concerning the relationship between wound itch and
pain. Descriptors of wound itch were correlated with descriptors of wound pain.
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CHAPTER V
Results
Sample Characteristics
Participants. Persons (N = 200) with wounds being followed at the wound care center
were interviewed and their wounds assessed. Data from one participant were excluded from data
analysis due to the extent of missing data: data from 199 participants were included in the
analysis. Their ages ranged from 21 to 98 years with a mean age of 67 years. Participants
included 112 males (56%), 170 white persons (84%), including 95 (48%) who were married.
Wound-related itch, determined by combining positive responses about itch in or around the
wound, was reported by 56 (28%) of the 199 participants. Participants with wound-related itch
(n = 56, 28%) were compared to participants without wound-related itch (n = 143, 71.5%)
throughout the analyses. Mean age of those with wound-related itch was 62.73 years (SD = 14.44
years), which was lower (but not significantly lower, p = .52) than the mean age of those without
itch, 68.42 years (SD = 13.63 years). The itch and no itch groups were similar in terms of
participant characteristics (see Table 3). The group with wound-related itch included 30 males
(53%), 45 white persons (80%), including 32 (51%) who were married. Table 3 compares
participant characteristics between those with wound-related itch and those without woundrelated itch.
Not all patients seen at the wound care center participated in the study. A total of 18
persons refused to participate with three simply not wanting to participate, one not interested,
one depressed about the wound, two suspicious, two citing lack of time, three with family
members stating not enough time, two denying sensation and symptoms, and four stating the
wound being followed had healed. Several were not included due to skin conditions and
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extensive rashes. Ten patients were too confused to answer questions appropriately.

One

patient was deaf and had communication difficulties. Three patients did not speak English. One
patient was agreeable to participate in the study but fell asleep as the study was introduced.
Table 3
Participant Characteristics
_____________________________________________________________________________
Participant Characteristic (X2) 

Wound-related Itch
(n = 56)

No Itch
(n = 143)

Total
(n = 199)

Gender (X2 = .23, p = .63)
Male
30
82
112
Female
26
61
87
Race (X2 = 3.51, p = .32)
White
45
124
169
Black
9
18
27
Hispanic
1
0
1
Country (X2 = 10.89, p = .37)
USA
52
135
187
Canada
1
1
2
Marital Status (X2 = 5.37, p = .25)
Married
32
63
95
Widowed
10
33
43
Never married
10
22
32
Education (X2 = 4.5, p = .72)
Completed 2 to 4 years of college
19
41
60
Completed high school
14
44
58
2
Employment Status (X = 13.15, p = .02)*
Retired
20
76
96
Unemployed
19
24
43
Employed full-time
13
20
33
General Health (X2 = 5.27, p = .15)
Good
21
67
88
Fair
25
49
74
Poor
4
22
26
______________________________________________________________________________
Note. * denotes significance: p < or = .05.
Using chi-square (X2) test of independence, a significant difference was found between
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groups in terms of employment status (X2 [2, N = 172] = 13.15, p = .02) with fewer participants
with itch (n = 20, 35.7%) being retired compared to participants without itch (n = 76, 53.1%),
and more participants with itch (n = 19, 33.9%) being unemployed compared to participants
without itch (n = 24, 16.8%). No other significant differences were found between groups for
other characteristics including gender, race, marital status, education, or general health status.
Participants presented with varying medical conditions.

The most frequent co-

morbidities as reported in the medical record are listed in Table 4. More than 62% were
identified with a history of hypertension.
Table 4
Frequency of Most Commonly Occurring Co-morbidities
_____________________________________________________________________________
Co-morbidity

Wound-related Itch
(n = 56)

No Itch
(n = 143)

Total (%)
(n = 199)

Hypertension

33

91

124 (62.3%)

Diabetes mellitus

19

60

79 (39.7%)

Arthritis

23

51

74 (37.2%)

Chi-square tests of association were used to compare participants with and without
wound-related itch based on 26 medical diagnoses. Wound-related itch occurred significantly
more in persons with deep vein thrombosis (DVT) (X2 [1, N = 199] = 5.11, p = .02) and with
intravenous drug abuse history (IVDA) (X2 [1, N = 199] = 4.43, p = .04). Among those persons
with a DVT history (n = 40, 20.1%), proportionally more (n = 17, 30.4%) reported woundrelated itch than those persons without itch (n = 23, 16.1%). Although only a total of four
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participants had a history of IVDA, proportionally more (n = 3, 5.4%) reported wound-related
itch than those without itch (n = 1, 0.7%).
Wounds. Each participant’s largest or most bothersome wound was assessed. Table 5 depicts
wound parameters including wound type, wound location, and wound age.
Table 5
Wound Parameters
______________________________________________________________________________
Wound Parameter (X2)

Wound-related Itch

No Itch

Total

Wound Type (X2 = 10.24, p = .12)
Traumatic

10

27

37(18.9%)

Pressure

6

27

33 (16.8%)

Diabetic/neuropathic

5

26

31(15.8%)

Venous*

14

17

31(15.8%)

Arterial

7

16

23 (11.7%)

Mixed vascular

0

3

3 (1.5%)

Other

13

25

38 (19.4%)

Head/trunk/upper extremities

3

23

26 (13.1%)

Lower extremities

53

119

172 (86.9%)

<1 week

2

7

9 (4.8%)

1 week to 1 month

6

19

25 (13.3%)

>1 to 6 months

19

60

79 (42.0%)

Wound Location (X2 = 4.14, p = .04)*

Wound Age (X2 = 4.88, p = .56)
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Wound Parameters (Continued)
______________________________________________________________________________
Parameter (X2)

Wound-related Itch No Itch

>6 months to 1 year

11

14

25 (13.3%)

>1 to 5 years

10

23

33 (17.6%)

5 to 10 years

3

4

7 (3.7%)

>10 years

3

7

10 (5.3%)

Total________

Sensation around Wound (X2 = 9.35, p = .03)*
3 areas sensed

25

50

75 (38.9%)

2 areas sensed

12

25

37(19.2%)

1 area sensed

12

22

34 (17.6%)

0 areas sensed

5

42

47 (24.4%)

____________________________________________________________________________
Note. * denotes significance: p < or = .05.
Wound Type. Wound type was determined by physician diagnosis as included in the
patient record or by presentation if a diagnosis was not documented. Chi-square analysis did not
show that type of wound was significantly associated with wound itch; however, there were
proportionally more venous wounds with wound-related itch (n = 14, 55%) than wound-related
itch in other types of wounds.
Wound Location. For wound location, head, trunk and upper extremity wounds were
grouped together for comparison to lower extremity wounds, as there were comparatively so
many lower extremity wounds. Chi-square analysis showed a greater likelihood for wounds in
the lower extremities to be itchy versus wounds in other areas of the body (X2 [1, N = 198] =
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4.14, p = .04). Only three (11.5%) of upper body wounds itched compared to 53 (30.8%) of
lower extremity wounds that itched.
Wound Shape. Most wounds (n = 94, 47.2%) were round, followed by those with an
irregular shape (n = 72, 36.2%). No significance was found between wound shape and wound
itch.
Wound Age. Wound age ranged from less than one week to greater than 10 years with
the greatest number of wounds (n = 79, 42%) being present one to six months. No significance
was found between wound age and wound itch.
Sensation in the Area of the Wound.

Sensation in the area of the wound was

significantly associated with wound-related itch: X2 (3, N = 193) = 9.35, p = .03. Among
persons with no sensation in the area of the wound, proportionally fewer experienced woundrelated itch (n = 5, 10.6 %) than those who did not itch (n = 42, 89.4%).
Research question #1: What is the frequency, timing, duration, and intensity of itch
related to chronic wounds?
Frequency. Wound-related itch was reported by 56 (28.1%) participants. Of the 56
participants who responded that they had wound-related itch in the interview, 44 had stated so in
response to the screening question, and 12 had not. Nine participants who said they had woundrelated itch at the time of the screening questions did not identify wound-related itch during the
interview.
Timing. Timing of itch was difficult to capture. People often responded that the wound
itched whenever the dressing was removed, but this response was not recorded. The most
frequent response about timing of wound-related itch was in the night (n = 15), followed by in
the evening (n = 14), in the morning (n = 6), and during the day (n = 1). No seasonal variation
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was found.
Duration. Wound-related itch was described as intermittent by 51 participants (98.1%)
versus one person who described it as continuous. The most frequent response given about
duration of wound-related itch episodes was minutes. The longest episode of wound-related itch
was described by one participant as lasting “hours and hours.”
Intensity. Participants rated intensity of a typical episode of wound-related itch on a
scale of one-to-ten, with 1 meaning none and 10 meaning unbearable. Mean response was 5.59
(SD = 2.88). Most participants ( n = 22, 51.2%) rated the result of scratching as highly
pleasurable, while one person (2.3%) rated the result of scratching as highly unpleasurable.
Research question #2: What is the relationship between wound characteristics and itch?
Characteristics of wounds were assessed with the Bates-Jensen Wound Assessment Tool
(BWAT), which assesses 13 wound characteristics with ordinal response scales coded one
through five. The scales are summated to arrive at a total BWAT score with higher scores
indicating more serious wound degeneration and lower scores indicating tissue health and wound
regeneration. Measurement of wound surface area (length x width) was also examined as an
alternative to the Bates-Jensen ordinal measure. The association of each characteristic to wound
itch was evaluated. When t-test results are reported, the values for equal variance not assumed
were used if Levene’s test for equality of means was significant; these values are used when ttest results are reported in the text.
Wound Measurement. Measurement of wound surface area ranged from 0.01 to 176
cm2 (M = 9.05, SD = 21.9) for wounds without itch, compared to 0.16 to 567 cm2 (M = 20.95, SD
= 78.4) for wounds that itched. This difference was not significant, t (58.4) = -1.78, p = .08.
The presence of one very large wound among the wounds that itched could have skewed this
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comparison. With this outlying measurement replaced with the next smallest value in the
distribution, 176cm2, by the process of Winsorizing, a significant difference was found between
wounds that itched and those that did not: t (72.71) = -2.38, p = .02, d = .50, 95% CI[-21.88, 1.92].
Size Category. Wound size (length x width) was categorized on a 1-to-5 scale from 1
for l x w < 4 sq cm2 to 5 for l x w > 80 sq cm2. There was a significant linear association
between wound size category and itch: point-biserial correlation = .260, p < .001. See Table 6.
Treating the size categories as nominal, there was a significant association between itch and
wound size category: X2 (4, N = 199) = 13.54, p = .009. Itch was reported significantly more
often in Categories 4 and 5 than in Category 1. These results are shown in Figure 3 and Table 6.

Figure 3. Proportion of cases with itch within each wound size category. The larger the wound the
greater the itch. Compared to < 4 squ cm category a higher probability of itch was associated with
36 -<80 squ cm, p = .022; and 80+ squ cm, p = .008. Also shown are the 95% confidence intervals, N =
199. * p < .05, **p < .01.
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Depth. Wound depth did not differ between wounds that itched and those that did not
itch: t (114.16) = 0.18, p = .86, d = .03, 95% CI [-0.27, 0.03].
Edges. Wound edges did not differ between wounds that itched and those that did not
itch: X2 (4, N = 199) = 2.44, p = .79.
Undermining. Chi-square analysis of wound itch and undermining was not significant:
X2 (4, N = 198) = 8.79, p = .07. Too few wounds had undermining for analysis. However, the
independent samples t-test showed that significantly more wounds with related itch had no
undermining: t (195.05) = 2.38, p = .02, d = .29, CI[0.04, 0.42].
Necrotic Tissue Type. Necrotic tissue type did not differ between wounds that itched
and those that did not itch: X2 (4, N = 198) = 4.26, p = .33.
Necrotic Tissue Amount. The amount of necrotic tissue in the wound base did not differ
between wounds which itched and those that did not itch: t (104.20) = -1.24, p = .22, d = .19,
95% CI[-0.83, 0.19]. However, greater itch was associated with Category 4 than with Category
1. See Figure 4 and Table 6.
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Figure 4. Proportion of cases reporting itch within each category of necrotic tissue amount. Compared to
none visible, more itch was reported for Category 4 >50 and <75%, p = .039. Also shown are the 95%
confidence intervals, N = 199. * p < .05.

Exudate Type. No significance was found between wounds which itched and those that
did not itch related to exudate type: X2 (4, N = 198) = 5.49, p = .24.
Exudate Amount. There was a significant association between exudate amount and itch
(X2[4, N = 198] = 11.68, p = .02). Greater itch was associated with Category 4, moderate
amount, than with Category 1, none, p = .05. See Figure 5 and Table 6.
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Figure 5. Proportion of cases reporting itch within each exudate amount category. Compared to the
amount of itch reported for wounds with no exudate, more itch was reported for wounds with a
moderate amount of exudate, p = .050. Also shown are the 95% confidence intervals, N = 199. * p < .05.

Skin Color Surrounding Wound: Skin color surrounding the wound did not differ
between wounds that itched and those that did not itch: X2 (4, N = 198) = 3.20, p = .53.
Peripheral Tissue Edema. Wounds with edema were more likely to itch: t (88.38) = 2.20, p = .03, d = .37, 95% CI[-0.93, -0.05]. A significant difference in column proportions was
found between those in the category of pitting edema < 4 cm around the wound and those in the
category of no swelling or edema. See Figure 6 and Table 6.
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Figure 6. Proportion of cases with itch within each category of edema. Compared to no swelling a higher
probability of itch was associated with pitting < 4 cm, p = .008. Also shown are the 95% confidence
intervals, N = 197. ** p < .01.

Induration. Although the Student’s t-test showed a linear relationship between wound
itch and induration, only seven wounds demonstrated induration.

X2 analysis showed no

significant difference between wounds that itched and those that did not itch related to
induration: X2 (3, N = 197) = 5.55, p = .14.
Granulation Tissue. Wounds with granulation tissue present in the base were more
likely to itch: X2(4, N = 198) = 8.06, p = .09 . Compared to those in the Skin intact category, a
higher probability for itch was associated with the categories of beefy or filled 75% to 100% (p =
.035), and beefy or filled 25% to 75% (p = .044). See Figure 7 and Table 6.
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Figure 7. Proportion of cases with itch within each category of granulation tissue. Compared to skin
intact a higher probability of itch was associated with beefy or 75% to 100 % filled, p = .035; and beefy
or <75% and > 25% filled, p = .044. Also shown are the 95% confidence intervals. Note the asymmetry of
the interval since proportions cannot be less than one, N = 198. * p < .05.

Epithelialization. No significance was found between wounds that itched and those that
did not itch for wound epithelialization: X2 (4, N = 198) = 1.47, p = .83.
Table 6 summarizes and compares the results of five different tests of statistical
association used in the analysis of the Bates-Jensen Wound Assessment Tool items: (a) the
Spearman rank order correlation, (b) Student’s t-test assuming equal within-group variance, (c)
unequal variance t-test as used where Levene’s test for unequal variance was significant, (d)
Pearson chi-square, and (e) binary logistic regression. As a measure of the magnitude of linear
association, the point-biserial correlation is also shown. The Student’s t-test is a test of the
significance of the point-biserial correlation.

Wound size, peripheral edema, and tissue

induration were linearly associated with itch (p < .05). Necrotic tissue amount, exudate amount,
peripheral edema, and granulation tissue showed significantly elevated itch within categories.
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Table 6.
Comparison of p Values for Different Statistical Tests of Association Between Bates-Jensen Wound
Characteristics and Self-reported Wound Itch

Wound
Characteristic

1. Wound size
category
2. Wound depth

p Value
Binary Logistic
SpearPoint
Unequal
Regression
man’s
biserial
Stuvariance Pearson
rank
correlation
dent’s t- t-testc
Chia order
coefficient
test
square
Category
correlab
2
3
4
tion
.001
.0002
.002
.009
.022
.260
. 148
.054

Comment

5
.008 See Figure 3.

-.012

.852

.8667

.690

.54

.25

.35

3. Wound edges

-.055

.511

.4390

.781

.647

.513

.274

4. Wound
undermining
5. Necrotic
tissue type
6. Necrotic
tissue amt.
7. Exudate
type

-.123

.041

.0837

.135

.077

.0583

.329

.427

.155

.584

.081

.087

.148

.2244

.202

.119

.244

.039

.335 See Figure 4.

.053

.469

.4582

.833

.999

.579

.366

8. Exudate
amount
9. Skin color

.110

.233

.1244

.021

.153

.716

.050

1.00 ML estimate
does not exist.
.
1.00 See Figure 5.

.080

.110

.2602

.533

.999

.579

.366

10. Peripheral
edema
11 Tissue
induration
12 Granulation
tissue
13. Epithelialization

.164

.012

.0211

.031

.052

.291

.144

.008

.144

.020

.0438

.118

.135

.162

-.040

.675

.5763

.552

.089

.035

.044

.217

.120 Only 7 with
induration.
.475 See Figure 7.

.045

.747

.5272

.823

.563

.522

.271

.424

.018

.175

1.0 Category 5
was reference.
.625

.067

Too few to
estimate.

.467

1.00 ML estimate
does not exist.
.418 See Figure 6.

Notes. The statistics used were Spearman’s rho, Student’s t, Unequal variance t-test, Pearson chi-square, and binary
logistic regression.
a

The point-biserial correlation is a measure of magnitude of linear association and the corresponding test of significance is
Student’s t-test.
b

Spearman’s rank order correlation is nonparametric measure of monotonic association and captured two effects not
found using binary logistic regression.
c

This result is shown only when the Levene test of equal variance is rejected.

Inspection of the condition probabilities in the Crosstabs tables showed a general
tendency for itch to be more highly associated with the middle rather than the end categories.
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This was apparent in significant logistic regression findings for necrotic tissue amount, exudate
amount, peripheral edema, and granulation tissue. See Figures 3 through 7.
Total scores of the Bates-Jensen Wound Assessment Tool ranged from 15 to 46 along the
Wound Status Continuum with no significant difference found between wound itch and total
score: X2 (7, N = 197) = 10.85, p = .15. Total scores fell between wound regeneration and
wound degeneration.
Research question #3: What treatments do participants use to manage wound itch?
Wound itch treatment options were selected by 59 participants. See Table 7.
Table 7
Treatments Used for Wound-related Itch
_____________________________________________________________________________
Treatment

Number of Responses

Percent of Responses____________

Rubbing the area

29

14.5

Scratching the area

24

12.0

Lotion

20

10.0

Vaseline or petrolatum

9

4.5

Hot or warm water

8

4.0

Antihistamine pill

7

3.5

Steroid cream

6

3.0

Watching TV

6

3.0

Cold pack

5

2.5

Steroid ointment

4

2.0

Cool shower or bath

3

1.5
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Treatments Used for Wound-related Itch (Continued)
_____________________________________________________________________________
Treatment

Number of Responses

Percent of Responses____________

Listening to music

3

1.5

Antibiotic ointment

2

1.0

Epsom salt

2

1.0

Heating pad

1

0.5

Air blowing on

1

0.5

Menthol ointment

1

0.5

Menthol lotion

0

0

Antihistamine cream

0

0

Local anesthetic

0

0

______________________________________________________________________________

Additionally, participants mentioned treatment measures that they had used were not
included on the interview list: patting the area of the wound, crying, praying, yelling at the
saints, stomping a foot, vinegar, reading, walking, getting off of it (i.e., sitting), taking off the
dressing, baking soda, bearing it, massaging the area, egg crate, and skin prep. Although no one
admitted to using it, several participants mentioned that they would like to try pouring alcohol on
the wound to relieve the itch.
Research question #4: How does wound itch affect quality of life for these participants?
Independent samples t-tests were done on responses to the RAND-12 questions to
determine if there was a significant difference between responses about health from the
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participants with wound-related itch and participants without wound-related itch. No difference
was noted on the quality of life measures between participants with or without wound-related
itch. Independent samples t-tests of the Physical Component Scores as well as the Mental
Component Scores for participants with and without wound-related itch were also done with no
significant differences found between participants with and without wound-related itch.
Research question #5: What is the relationship between wound itch and pain?
Ratings of generalized pain and wound-related itch.

Generalized pain was assessed

using the items on the Brief Pain Inventory (i.e., pain location, pain interference, ratings of
worst, least, and average pain over the previous 24 hours, and a rating of present pain).
Participants were instructed to consider all pain, wound-related or any other bodily pain, while
responding to the Brief Pain Inventory. Seventy-two participants (36%) reported no pain. Pain
was rated on a 0-to-10 scale. The mean response for worst pain was 4.25 (SD = 3.62). Least
pain was rated with a mean of 1.26 (SD = 2.02). Average pain was rated with a mean of 3.21
(SD = 6.69). This compares to the mean score of 2.17 (SD = 2.89) for pain now. An overall
intensity rating for pain was not obtained, but a Pain Severity Score was calculated as a mean of
the responses for worst pain, least pain and average pain, at 2.91.
Average pain was defined as the average level of all pain in the last 24 hours prior to the
interview. Because wound itch intensity was described as the rating for itch intensity over 24 to
48 hours prior to the interviews, average pain (M = 3.21, SD = 6.69) was correlated with wound
itch intensity (M = 5.59, SD = 2.88) for a significant positive correlation (r = .42, p = .002).
Wound-related pain compared to wound-related itch.

Interview questions about

wound-related pain (in or around the wound) were also asked. Participants (N = 199) responded
regarding wound-related pain: 98 (49%) responded positively to confirm the presence of wound-
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related pain; 101 (51%) responded negatively. This pattern contrasts with wound-related itch,
about which 56 (28%) of participants responded positively to confirm the presence of woundrelated itch, and 143 (71.5%) responded negatively. Wound-related pain correlated with woundrelated itch for a significant positive correlation (r = .17, p = .02).
Pain in and around the wound compared to itch in and around the wound.

Pain

around the wound was described by 39.2% of participants compared to 26.6% who described
itch around the wound. Pain in the wound was described by 44.2% of participants compared to
only 9.5% who described itch in the wound. Participants were asked to further rate the amount
of pain and itch in and around the wound on a zero-to-ten scale. Mean rating for pain on the
wound was 2.59 (SD = 3.43). This correlated positively (r = .24, p = .001) with the mean rating
for the amount of itch on the wound, which was only 0.49 (SD = 1.79). Mean rating for amount
of pain around the wound was 2.35 (SD = 3.29), which correlated positively (r = .34, p <.001)
with the mean rating for the amount of itch around the wound, which was 1.43 (SD = 2.80).
Descriptors of pain compared to descriptors of itch. Table 8 depicts the mean scores
each descriptor received related to itch and related to pain, arranged by itch score. Descriptors
receiving the highest ratings for itch were itching, annoying, and bothersome. Descriptors
receiving the highest ratings for pain were annoying, bothersome, and bothering. Paired sample
t-test analysis was done to compare ratings of the descriptors for itch to ratings for pain.
Bonferoni analysis against an alpha of .000125 (alpha of .05 divided by the number of
comparisons, which is 40) eliminated all significant findings between pain and itch descriptors.
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Table 8
Comparison of Scores for Wound Pain and Itch Descriptors (organized by itch score)
____________________________________________________________________________
Descriptor

Itch Score

Pain Score

t

Sig. (2-tailed)

95% CI____

Itching

3.48

0.60

4.49

<.01

1.04, 2.80

Annoying

2.87

3.37

-1.14

---

-0.77, 0.22

Bothersome

2.63

3.19

-0.86

---

-0.97, 0.40

Bothering

2.30

3.15

-1.98

---

-1.16, 0.02

Only desire no itch

2.23

0.41

5.91

<.01

1.21, 2.53

Unpleasant

2.17

3.01

-1.75

---

-1.21, 0.10

Stubborn

1.83

2.26

-1.52

---

-1.03, 0.16

Insistent

1.67

2.17

-1.29

---

-1.09, 0.25

Disturbing my sleep 1.63

2.10

-0.98

---

-0.87, 0.31

Disgusting

1.58

2.07

-1.41

---

-1.42, 0.26

Severe

1.54

2.10

0.10

---

-0.82, 0.90

Awful

1.52

1.93

-1.29

---

-1.06, 0.24

Tiresome

1.49

2.26

-1.05

---

-1.37, 0.44

Tickling

1.49

0.29

2.26

.03

0.08, 1.63

Prickling

1.45

0.87

0.92

---

-0.50, 1.30

Inflaming

1.44

1.56

-0.46

---

-0.63, 0.40

Tiring

1.44

1.88

-1.33

---

-1.42, 0.30

Tingling

1.42

1.15

.00

1.0

-0.67, 0.67

Unbearable

1.36

1.45

0.44

---

-0.54, 0.84
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Comparison of Scores for Wound Pain and Wound Itch Descriptors (Continued)
____________________________________________________________________________
Descriptor

Itch Score

Pain Score

t

Sig. (2-tailed)

95% CI____

Comes in waves

1.35

2.09

-1.82

---

-1.56, 0.10

Dreadful

1.34

1.32

0.20

---

-0.74, 0.90

Burning

1.32

1.72

-1.98

---

-1.36, 0.03

Unmanageable

1.31

1.12

1.56

---

-0.18, 1.29

Terrible

1.30

1.67

0.22

---

-0.71, 0.88

Stinging

1.28

1.68

-2.79

.01

-1.67, -0.25

Uncontrollable

1.27

1.11

0.69

---

-0.48, 0.96

Hurting

1.20

3.07

-3.37

.002

-2.15, -0.52

Mosquito-bite like

1.20

0.23

3.89

.001

0.54, 1.75

Oppressive

1.15

1.73

-2.29

.03

-1.59, -0.08

Torturing

1.13

1.40

0.11

---

-0.73, 0.81

Restricting my life

1.10

2.29

-3.26

.003

-2.38, -0.54

Acute

1.05

1.63

-1.52

---

-0.97, 0.15

Pinprick-like

1.00

0.87

0.85

---

-0.46, 1.10

Painful

0.96

3.10

-3.49

.002

-2.53, -0.65

Sharp

0.96

2.26

-4.21

<.01

-2.15, -0.74

More when warm

0.96

0.67

-0.79

---

-1.05, 0.47

Pricking

0.91

0.87

-0.13

---

-0.67, 0.59

Warm

0.90

0.94

-1.38

---

-1.29, 0.25

Ant-like

0.87

0.16

2.67

.01

-0.03, 1.16
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Comparison of Scores for Wound Pain and Wound Itch Descriptors (Continued)
____________________________________________________________________________
Descriptor

Itch Score

Pain Score

t

Sig. (2-tailed)

95% CI____

Penetrating

0.86

1.91

-0.99

---

-1.03, 0.36

Throbbing

0.75

2.01

-4.25

---

-2.47, -0.86

Pulsating

0.69

1.59

-2.74

.01

-2.01, -0.29

Hot

0.63

0.74

-0.97

---

-0.96, 0.35

Like sunburn

0.61

0.35

1.97

---

-0.03, 1.16

More when cold

0.31

1.11

-1.77

---

-1.60, 0.13

_____________________________________________________________________________
Note. Descriptors with negative t-tests are more associated with pain; descriptors with positive ttests are more associated with itch.
Additional Analysis
Paired samples t-tests were done between treatments used for wound-related itch and
treatments used for bodily itch.

Antibiotic ointment, menthol ointment, menthol lotion,

antihistamine cream, capsaicin, and local anesthetic were selected for both types of itch equally.
Paired sample correlations for antihistamine pills (r = .45, p = .01) and watching TV (r = .47, p =
.007) showed the association of those methods of treatment for bodily and wound-related itch.
Rubbing the area was the only treatment with significant paired t-test results: t (30) = -3.50, p =
.001, 95% CI [-0.61, -0.16], so that rubbing the area was used significantly more for woundrelated itch than bodily itch.
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CHAPTER VI
Discussion
This study quantified and described wound-related itch. Greater than one fourth of
patients being seen at the wound care center reported wound-related itch.

Each wound

characteristic was explored to determine its association with wound itch. Some association was
found between wound itch and seven of the 13 Bates-Jensen wound characteristics. Greater
wound size, more peripheral edema and more tissue induration were found to be significantly
associated to wound itch (p < .05). Pain and itch were positively correlated. The effect of
wound itch on quality of life was not discerned.
Frequency of Wound Itch
Wound-related itch was described by approximately one fourth (n = 56, 28%) of 199
persons being followed for their wounds and is perhaps the most important finding of this study.
This finding both confirms and quantifies the existence of the wound itch phenomenon which,
until now, has been recognized clinically but not described in the literature. No previous studies
were found which quantified wound itch .
Participants were asked if they had itch related to their wound and, if so, were asked if
the itch was around the wound, in the wound, or both in and around the wound.

Then

participants with wound-related itch were asked to rate the amount of itch in the wound and/ or
around the wound. Because of the inconsistencies given between the questions, itch related to
the wound (in or around) was tallied. There was also inconsistency in some instances between
the screening question regarding wound-related itch and the responses given about woundrelated itch in the interview. The inconsistency of responses between the screening questions
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and the interview questions about wound-related itch may be attributed to misunderstanding or
minimizing the wound itch phenomenon, as more people reported wound- related itch in the
interview than in the screening questions.
That the participants with wound-related itch were elderly (M = 67.78, SD = 14.44)
requires that the phenomenon be further explored in varying age groups. It is well known that
aging skin tends to be prone to xerosis and pruritus (Baronoski, Ayello, Tomic-Canic, & Levine,
2012). Age-associated skin changes result in itchy skin as discussed by Norman (2003), Reddy
(2008), and Yosipovitch (2004a). Transepidermal water loss is increased in the very young and
the very old (Yosipovitch, 2004a). Xerosis is age-associated dry skin which is estimated to be in
30 to 60% of the adult population (Yosipovitch, 2004b).
Wound itch was found with and without sensation in the area of the wound. No persons
with spinal cord injury described wound-related itch.

Five of 34 persons with diagnosed

neuropathy described wound-related itch. Itch with limited sensation in the area of the wound
may be explained by a larger innervation area of itch-sensitive C-fibers (Schmelz et al., 1997) or
a central rather than peripheral neurological process.
Significantly more itchy wounds were found in the lower extremities (p = .04), in
persons with DVT (p = .02), and in persons with an injection drug use history (p = .04).
Compared to other wound types, a greater proportion of persons with venous wounds reported
wound-related itch.

These findings are consistent with the findings of Duque, Yosipovitch,

Chan, Smith, & Levy (2005) who found that 66% of persons with chronic venous insufficiency
describe wound-related itch. These findings are also consistent with previous findings of Paul,
Pieper, & Templin (2011) where 45.9% of persons with a history of injection drug use reported
itch in the legs and/or feet, and where itchiness correlated with degree of venous disease (r =.26,

85

p = .025). Dermatitis with itchiness is characteristic of venous disease (Sieggreen & Kline,
2012).

Persons with venous ulcers should therefore be assessed for itch and its deleterious

effects. It must be noted that other wound types including arterial, neuropathic, pressure and
traumatic wounds were also represented in the wound itch group.

All wound types must

therefore be considered as potential sources of wound itch.
Timing and Duration of Wound Itch
Timing and duration of wound-related itch were difficult to capture with patient recall
and as questioned.

In trying to describe time-of-day of wound-related itch, participants

frequently commented that wound-related itch occurred at the time of dressing change,
regardless of time-of-day. This outcome might occur due to exposure of the wound bed to air or
relief of pressure from the dressing. That most participants were bothered most by woundrelated itch in the night is similar to previous findings of Duque and colleagues (2005). Greaves
(2005) suggests that increased itch in the night may be related to skin temperature or circadian
rhythms of itch mediators.
Intensity of Wound Itch
Mean intensity of wound-related itch was 5.59 (SD 2.88) on a 1-to-10 scale. This can be
compared to the mean score for worst bodily pain of 4.25 (SD 3.62) on a 1-to-10 scale, so that
wound itch intensity was rated as worse than bodily pain.
Quality of Wound Itch
While participants had difficulty distinguishing and rating itch in and around their
wounds, they were able to distinguish wound-related itch from wound-related pain and choose
descriptors for each phenomenon. Descriptors receiving the highest ratings for wound-related
itch were itching, annoying, and bothersome.

Worrisome and aggravating were additional
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descriptors volunteered by participants for wound-related itch: these descriptors exemplify the
anxiety wound-related itch causes because of the unknown implications of the sensation.
Qualities of wound-related itch could be distinguished from other wound sensations and
confirmed wound-related itch as a negative sensation.
Wound Characteristics and Itch
The relationship of each wound characteristic to wound-related itch is discussed below.
Characteristics of wounds and their relationship to itch have not been previously described. No
association between wound itch and wound depth, wound edges, necrotic tissue type, exudate
type, skin color, or epithelialization was found. Linear relationships between wound size, tissue
edema, and tissue induration are discussed. Significantly elevated itch categories as found with
necrotic tissue amount, exudate amount, peripheral tissue edema, and granulation tissue are also
discussed.
Wound Size. Wounds that itched were larger than those which did not itch. The linear
association of wound size with wound itch supports the Theory of Wound Itch, which predicts
that the wound (the interrupted skin integrity) is what triggers itch. This notion contrasts with
the understanding that itch is specific to the skin (Yosipovitch & Papoiu, 2008), as skin is
damaged or missing in open wounds. Metze (2004) reported that itch could not be induced
where epidermis had been removed. Additionally, itch is not transmitted by nerves in the deeper
layers of the dermis and subcutaneous fat (Yosipovitch, Carstens, & McGlone, 2007), so the
tissues in the base of the wound are likely not the source of the itch sensation. The larger wound
border may produce more pruritogens such as histamine and growth factors which may explain
the greater itchiness of larger wounds.
Undermining. Wounds with undermining were less likely to itch.

Generalizations
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about undermining and itch should not be made as so few wounds were found with undermining.
Necrotic tissue amount. Necrotic tissue is dead tissue, which is typically brown or black
(Baranoski et al., 2012). It forms a blockage for wound healing, so removal of necrotic tissue
promotes wound healing.

While itch and necrotic tissue amount were not significantly

associated, greater itch was found associated with the category of >50% and <75% of wound
covered. Itch leads to scratch, which is an attack and remove response (Yosipovitch, Carstens, &
McGlone, 2007). Although potentially damaging, scratching may serve a physiologic purpose of
removing necrotic tissue by functionally debriding the wound to enable wound healing.
Exudate amount. More itch was noted at the fourth level, moderate, compared to other
categories of wound exudate, very possibly implicating maceration. Maceration is softening of
skin surrounding a wound due to excess drainage or moisture (Baranoski et al., 2012). Moderate
wound drainage can moisten and macerate the peri-wound area which may trigger itch.
Peripheral Tissue Edema. Edema mechanically stretches cells and tissues, which may
exacerbate itchiness. While histamine-sensitive C-nerve fibers are mechanically insensitive,
edematous changes of nerve fiber bundles that occurs with mast cell invasion may provoke or
aggravate itchiness (Sugimoto, Umakoshi, Nojiri, & Kamei, 1998). Additionally, other C-nerve
fibers exist, which are mechanically sensitive and are able to transmit itch (Yosipovitch,
Carstens, & McGlone, 2007). Histaminergic as well as non-histaminergic mechanisms for itch
have been found (Patel & Dong, 2010). Protease-induced itch is transmitted via mechanically
sensitive C-nerve fibers (Tey & Yosipovitch, 2011). A high probability of itch was associated
with pitting edema < 4 cm around wound compared to other categories of edema.

The

differences between response categories for edema on the Bates-Jensen Wound Assessment Tool
range from non-pitting edema at one end to extensive pitting and/or crepitus on the other; this
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finding may explain the category-associated increase in itch probability.

Itch might be

minimized by controlling edema.
Induration. Induration is firmness of the tissue indicative of further tissue damage in the
peri-wound area (Baranoski, Ayello, & Langemo, 2012). Induration was significantly associated
with wound itch; however, analysis is limited as only seven wounds demonstrated induration.
Induration is most likely related to inflammatory processes initiated by tissue damage and
pruritogens as released with mast cell degradation (Baranoski et al., 2012). The inflammatory
phase of wound healing is prolonged in chronic wounds (Doughty & Sparks-Defriese, 2007), so
itchiness with induration follows.
Granulation tissue. Granulation tissue is the beefy, red, velvety tissue found in actively
healing wounds. It is the hallmark of the proliferative phase of wound healing (Doughty &
Sparks-Defriese, 2009). Granulation tissue is composed of capillary loops and connective tissue
proteins with fibroblasts and inflammatory cells within. Granulation tissue in the base of the
itching wound fits the physiological understanding of itch in that granulation tissue indicates
active wound healing.

Wound healing brings histamine, nerve growth factor, and other

pruritogens into the wound (Tey & Yosipovitch, 2011). Friable granulation tissue that bleeds
easily can be produced excessively in cases of wound infection (Gardner & Franz, 2012), so
itching with excessive, friable granulation tissue and tissue induration (previously described)
could indicate an infectious process which may impair wound healing.
“It’s itching; it must be healing,” is a phrase heard frequently from health care providers
as well as patients with wounds. The accuracy of this saying remains unknown. Greater itch
found in upper categories of wound characteristics meant greater wound itch in more severe
wounds. Total scores of itching wounds fell along the Bates-Jensen Wound Status Continuum in
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the areas of regeneration and degeneration.
Treatments Used for Wound Itch
Wound-related itch motivated participants to actively seek treatment of the sensation.
Rubbing (n = 29, 14.5%) and scratching (n = 24, 12.0%) were found to be most frequently used
responses to wound-related itch followed by lotion (n = 20, 10.0%) and petrolatum (n = 9, 4.5%).
Scratching may be under-reported, as patients would often respond, “I know better than that,”
when the option of scratching was listed and would volunteer that they patted the area of the
wound in response to itching. These findings can be compared to those of Paul, Pieper, and
Templin (2011) in which most participants with venous disease used antibiotic ointment,
followed by petrolatum, scratching, and lotion. It is well known that pruritus induces scratching
(Weisshaar, et al., 2003). Conventional therapy for pruritus includes antihistamines (PogatzkiZahn et al., 2008). Emollients and anti-inflammatory agents are used to manage itch during scar
formation (Weisshaar et al., 2003).
Relationship of Wound Itch to Pain
Average generalized bodily pain, which included wound-related pain as well as any
bodily pain, was compared to wound-related itch intensity to determine the relationship of the
sensations. While a Pain Severity Score could be calculated based on other responses about
pain, a general pain intensity score was not obtained. Average pain was rated on a 0-to-10 scale,
while itch intensity was rated on a 1-to-10 scale. Average pain (M = 3.21, SD = 6.69) was
correlated positively (r = .42, p = .002) with itch intensity (M = 5.59, SD = 2.88).

These

findings are similar to those of Verhoeven and colleagues (2007) who found a moderate
correlation (r = .38-.49) among symptoms of itch, pain, and fatigue in patients with skin diseases
found in general practice. Intensity of wound-related itch correlated positively with intensity of
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wound-related pain (r = .17, p = .02). Painful wounds should also be assessed for itchiness.
Pain and itch are both subjective phenomena, dependent on self-report. Inconsistencies
in responses were noted between the yes/no answers about pain and itch in and around the
wound and ratings of amounts of pain and itch in and around the wound. Responses for woundrelated pain and wound-related itch were tallied to accommodate for the inconsistency. While
the amount of pain on the wound (M = 2.59, SD = 3.43) and around the wound (M = 2.35, SD =
3.29) was greater than the amount of itch on the wound (M = 0.49, SD = 1.79) and around the
wound (M = 1.43, SD = 2.80), the ratings were significantly positively correlated (r = .24, p =
.001 on the wound; r = .34, p < .001 around the wound). It is interesting to note that pain on the
wound was rated higher than pain around the wound, while itch around the wound was rated
higher than itch on the wound.
These findings demonstrate the close interaction between itch and pain. Itch sensitization
in the periphery and in the central nervous system has many similarities to pain sensitization
(Schmelz, 2010). Pain inhibits itch, while itch can be induced by exogenous opiates. Current
understanding of itch promotes the sensitivity and selectivity theories of itch (Patel &
Yosipovitch, 2010). The specificity theory suggests sensory neurons that are specific to itch
stimuli. The selectivity theory suggests that itch neurons can also be excited by painful stimuli.
Both theories have been supported by physiological findings (Patel & Yosipovitch, 2010). The
fact that pain and itch activate the same areas of the brain implies a different pattern of activation
for the two stimuli (Patel & Yosipovitch, 2010).
Nerve growth factor is a neuropeptide which regulates growth and function of nerve cells
and is likely found in wounds, as its main sources are keratinocytes and mast cells (Tey &
Yosipovitch, 2011). The amount of nerve growth factor is correlated with the severity of itching

91

and eruptions in atopic dermatitis, but pain results when nerve growth factor is injected into
normal skin (Stander & Schmelz, 2006; Tey & Yosipovitch, 2011). Depletion of neuropeptides
is a process that has been used to treat both itch and pain (Tey & Yosipovitch, 2011). As more
is learned about nerve growth factor and other physiological phenomena related to itch and pain,
a better understanding of the two sensations related to wounds should be gained.
Participants in the study were able to distinguish between the two sensations, both in
terms of sensation location and ratings as well as descriptors of the wound-related sensations.
Both sensations were described negatively: annoying and bothersome received high ratings for
both itch and pain.
Quality of Life
No differences were found between persons with and without wound-related itch in terms
of quality of life. Persons with chronic wounds have reported a negative impact on quality of life
(Essex, Clark, Warriner, & Cullum, 2009). Persons suffering from itch have reported poor
general health (Dalgaard, Svensson, Holm, & Sundby, 2004). In our previous study, persons
with itch in the legs or feet had poorer physical quality of life (Paul et al., 2010). As in the study
by Spilsbury and colleagues (2007), it was difficult to distinguish the effects of the wound from
the effects of other conditions.

The RAND-12 was chosen because of its usefulness in

determining participants’ overall mental and physical health quotients. Perhaps dermatological
quality of life instruments would have better captured quality of life as it was affected by wounds
and by itch.
Fit of Results with the Theory of Wound Itch
The Theory of Wound Itch as derived from Levine’s Conservation Model supposes that a
wound is the trigger for a physiological response, which can result in the itch sensation. Itch
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then triggers the desire to scratch and other measures to manage the itch with the goal of healing
and continuity of the individual. The assumptions of the Theory of Wound Itch were sustained.
Results of this study showed the frequency of wound-related itch in the participants with
chronic wounds, the characteristics of the wounds that itched versus those which did not, the
relationship of pain to wound itch, and measures used by participants to manage wound itch.
That wound itch was reported and quantified fits the Theory of Wound Itch. Characteristics of
wounds associated with wound itch were described.

A wound does not always trigger itch.

Both the selectivity theory and the specificity theory address the neurophysiology of itch and can
explain how itch and pain can be triggered.

Regulation and protection are empirically

represented by scratching as well as other measures taken in response to wound itch. Nursing
intervention for management of wound-related itch was not explored in this study but would be
represented by protection. The effect of wound itch on quality of life was not detected in this
study, but further research may determine the effect of wound itch on continuity using other
measures evaluating different aspects of quality of life.
Limitations
Research subjects were patients who were followed at a suburban wound care center.
The sample may be representative of a more educated population with a higher socioeconomic
status than other populations.

Participants were approached consecutively, not with any

randomization, so that generalizability of the findings is limited.
Atopy involves a personal or family history of asthma, allergic rhinitis and atopic
dermatitis (Hanifin & Rajka, 1980) and may have been a confounding factor in the study as it
predisposes the person to pruritus.

While rashes are visible and were examined for

determination of inclusion in the study, approximately 17% of the general population has atopic
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dermatitis or eczema (Yosipovitch, 2004b), likely not diagnosed.
The in-depth process of rating pain and itch descriptors was difficult for persons with
impaired or low-level cognitive functioning.

The very elderly participants demonstrated

difficulty with numeric scales.
While the data were collected completely by the primary investigator, providing
consistency throughout this study, another wound care specialist may have rated the same wound
characteristics quite differently.

Drainage amount and color were especially difficult to

categorize with one-time wound assessments. Wound odor is not part of the Bates-Jensen
Wound Assessment Tool but may be a wound characteristic with significance to itch. No option
is given for adherent brown eschar, which was a frequent finding.
A particular timeframe was not specified for the Paul-Pieper Itching Questionnaire.
Timing was clarified as one or two days prior to the interview. A 24-hour timeframe was too
restrictive. Additionally, many of the treatment options for itch listed in the questionnaire were
never selected. Alcohol might be a treatment option to add, as several participants reported that
they wished to apply alcohol topically to the itchy area. Participants volunteered aggravating
and worrisome as appropriate descriptors for wound-related itch. Duration of itch and length of
time without itch required prompts.

Seasonal variation could usually not be recalled or

described.
Patients were settled into an examination room with dressings removed and topical 2%
Lidocaine jelly (Akorn, Inc.) applied over the wound before they were approached for inclusion
in the study. Additionally, 4% Lidocaine topical solution (Qualitest ®) was sometimes added
during the visit if requested by the patient. Use of the monofilament to assess sensation in the
area of the wound was done outside of the area of topical Lidocaine application; however,
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sensation in the area of the wound was likely affected by the Lidocaine. Timing of most recent
procedure was not collected, as most wounds were debrided at each visit.
Conclusion
This study was innovative in that it explored wound itch, which is documented clinically,
but is not well described in the literature. Linear associations of wound itch with wound size and
tissue edema were found. Greater itch was described with more severe wounds as evidenced by
greater wound size, more necrotic tissue, and moderate wound exudate. Greater itch associated
with more granulation tissue may reflect the associated pruritogens in the base of granulating
wounds. Qualities of wound itch were examined and compared to wound pain, further defining
the similarities and differences between the sensations of pain and itch. So many variables may
play into the subjective experience of itch as it occurs related to chronic wounds. Findings of
this study increase general knowledge and awareness of wound itch and its impact on the
individual. Successful management of wound itch can improve healing and quality of life for
persons with wounds and positively impact society as a whole.
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APPENDIX A
PARTICIPANT SCREENING TOOL
Date (mo/day/year) ___________ Collection time __________ Code __________
Data Collector Initials (first and last initial, printed) ___ ___
Wound Care Center location ____________
1. You are being asked to participate in a research study about wound itch. Are you willing to
answer a few questions to determine if you are eligible to participate?
___Yes
___No
(If the answer is “no,” respond, “Okay, thank you. We will not be asking more of you,” and do
not proceed.
If the answer is “yes,” continue.)
2. Do you have a wound that is being seen here at the wound care center?
___Yes
___No
(If the answer is “no,” respond, “Okay, thank you. We will not be asking more of you,” and do
not proceed.
If the answer is “yes,” continue.)
3. Are you 18 years old or older?
___Yes
___No
(If the answer is “no,” respond, “Okay, thank you,” and do not proceed.
If the answer is “yes,” continue.)
4. (If the respondent is female) Is there any possibility that you are pregnant?
___Yes
___No
(If the answer is “yes,” respond, “Okay, thank you. We will not be asking more of you,” and do
not proceed.
If the answer is “no,” continue.)
5. Do you have a rash in any area of your body?
___Yes
___No
(If the answer is “yes,” estimate if the area of the rash is greater than 20% of body surface area.
If the rash area is greater than 20% of body surface, respond, “Okay, thank you. We will not be
asking more of you” and do not proceed.
If the answer is “no” or if the area of rash is 20% of body surface area or less, continue.)
6. Do you have a rash in the area of the wound?
___Yes
___No
(If the answer is “yes,” respond, “Okay, thank you. We will not be asking more of you” and do
not proceed.
If the answer is “no,” continue.)
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7. Does your wound itch?
___Yes

___No

(Proceed with, “Okay; we will continue once you are in a private room.”)
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APPENDIX B
INFORMATION SHEET
Project: Itch Occurring with Chronic Wounds
Principle Investigator: Julia Paul, RN, MSN
Location: Beaumont Hospital Wound Care Center – Royal Oak; private office of Dr. Tad Sprunger - Troy
Purpose:
You are being asked to be in a research study to obtain information about your wound and related
symptoms, including itch and pain. This study will be conducted at William Beaumont Hospital in Royal
Oak and at the private office of Dr. Tad Sprunger in Troy.
Study Procedures:
If you take part in the study, you will be asked to have your wound assessed and photographed, have
sensation assessed in the area of the wound using a hand-held instrument with a fishing-line-like tip, and
answer questions in a one-time interview during your visit. The wound assessment will be done with your
usual wound assessment. The interview portion of the study will take approximately 45 minutes. Your
medical record will be accessed to obtain information including diagnoses, medical history, medications
and allergies. This information will be used to gain a better understanding of itch related to wounds.
Benefits:
There will be no direct benefits for you.
Risks:
The only risk of this study is the potential risk of loss of confidentiality. We are very concerned about
your privacy and will make every effort to maintain the security of your records.
Costs/Compensation:
There will be no costs to you for participation in this research study. For taking part in this study, you
will receive $10 (U.S. dollars) for your time and inconvenience. Payment will be given to you when the
wound assessment and interview have been completed.
Confidentiality:
All information collected from you will be kept confidential, without any identifiers. You will be
identified in the research records by a code name/number. Photographs will be edited if necessary to deidentify you as much as possible.
Voluntary Participation/Withdrawal:
Taking part in this study is voluntary. You may choose not to take part in this study, or if you decide to
take part, you can change your mind later and withdraw from the study. You are free to not answer any
questions or withdraw at any time. Your decision will not change any present or future relationships with
William Beaumont Hospital or its affiliates.
Questions:
If you have any questions about this study now or in the future, you may contact Julia Paul at 248-8980401. If you have questions or concerns about your rights as a research participant, please contact the
Beaumont Hospital Human Investigation Committee at (248)551-0662 or the Wayne State University
Human Investigation Committee at (313)577-1628.
Participation:
By proceeding with the wound assessment and interview, you are agreeing to participate in this study.
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APPENDIX C
RECEIPT OF PATIENT INFORMATION SHEET AND RECEIPT OF
COMPENSATION
HIC # 2010-230
Itch Occurring with Chronic Wounds

The participant, _________________________, received the Itch Occurring with Chronic
Wounds Information Sheet and has agreed to participate in the study.

Researcher signature:__________________________________________________
Date:________________________________________________________________

The participant, ___________________________, received ten dollars ($10) for
participation in the study entitled “Itch Occurring with Chronic Wounds.”

Researcher signature:___________________________________________________
Date:_________________________________________________________________
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APPENDIX D
BATES-JENSEN WOUND ASSESSMENT TOOL
Location: Anatomic site. Identify right (R) or left (L) and use an “X” to mark site on body
diagram.
__Sacrum/ coccyx
__Lateral ankle
__Trochanter
__Medial ankle
__Ischial tuberosity
__Heel
__Other site

Shape: Overall wound pattern; assess by observing perimeter and depth. Circle the appropriate
descriptor.
__Irregular
__Linear or elongated
__Round/ oval
__Bowl/ boat
__Square/ rectangular
__Butterfly
__Other shape

Item
1. Size

2. Depth

3. Edges

Assessment
1 = length x width < 4sq cm
2 = l x w 4-<16sq cm
3 = l x w 16.1-<36sq cm
4 = l x w 36.1-< 80sq cm
5 = l x w > 80sq cm
1 = Non-blanchable erythema on
intact skin
2 = Partial thickness skin loss
involving damage or necrosis
3 = Full thickness skin loss involving
damage or necrosis of subcutaneous
tissue; may extend down to but not
through underlying fascia; &/or
mixed partial & full thickness &/or
tissue layers obscured by granulation
tissue
4 = Obscured by necrosis
5 = Full thickness skin loss with
extensive destruction, tissue necrosis
or damage to muscle, bone or
supporting structures
1 = Indistinct, diffuse, none clearly
visible
2 = Distinct, outline clearly visible,
attached, even with wound base
3 = Well-defined, not attached to
wound base
4 = Well-defined, not attached to
base, rolled under, thickened
5 = Well-defined, fibrotic, scarred or
hyperkeratotic

Score

100

4. Undermining

5. Necrotic tissue type

6. Necrotic tissue amount

7. Exudate type

8. Exudate amount

9. Skin color surrounding
wound

10. Peripheral tissue
edema

11. Peripheral tissue
induration

12. Granulation tissue

1 = Not present
2 = Undermining < 2 cm in area
3 = Undermining 2-4 cm involving
<50% wound margins
4 = Undermining 2-4 cm involving
>50% wound margins
5 = Undermining > 4 cm or tunneling
in any area
1 = None visible
2 = White/grey non-viable tissue
and/or non-adherent yellow slough
3 = Loosely adherent yellow slough
4 = Adherent, soft, black, eschar
5 = Adherent, hard, black, eschar
1 = None visible
2 = <25% of wound bed covered
3 = 25% to 50% of wound covered
4 = > 50% and <75% of wound
covered
5 = 75% to 100% of wound covered
1 = None
2 = Bloody
3 = Serosanguinous: thin, watery,
pale
4 = Serous: thin, watery, clear
5 = Purulent: thin or thick, opaque,
tan/yellow, with or without odor
1 = None: dry wound
2 = Scant: wound moist but no
observable exudate
3 = Small
4 = Moderate
5 = Large
1 = Pink or normal for ethnic group
2 = Bright red &/or blanches to touch
3 = White or grey pallor or
hypopigmented
4 = Dark red or purple 7/or nonblanchable
5 = Black or hyperpigmented
1 = No swelling or edema
2 = Non-pitting edema extends <4 cm
around wound
3 = Non-pitting edema extends > or =
4 cm around wound
4 = Pitting edema extends < 4 cm
around wound
5 = Crepitus &/or pitting edema
extends > or = 4 cm around wound
1 = None present
2 = Induration, < 2 cm around wound
3 = Induration 2-4 cm extending <
50% around wound
4 = Induration 2-4 cm extending > or
= 50% around wound
5 = Induration > 4 cm in any area
around wound
1 = Skin intact or partial thickness
wound
2 = Bright, beefy red, 75% to 100%
of wound filled &/or tissue
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13. Epithelialization

overgrowth
3 = Bright, beefy red; < 75% and >
25 % of wound filled
4 = Pink, &/or dull, dusky red &/or
fills < or = 25% of wound
5 = No granulation tissue present
1 = 100% wound covered, surface
intact
2 = 75% to < 100% wound
covered&/or epithelial tissue extends
> 0.5 cm into wound bed
3 = 50% to < 75% wound covered
&/or epithelial tissue extends < 0.5
cm into wound bed
4 = 25% to < 50% wound covered
5 = < 25% wound covered

Total score
14. Sensation of monofilament in the area of the wound:
(3)__3 areas sensitive
(2)__2 areas sensitive
(1)__1 area sensitive
(0)__No areas sensitive
15. Current dressings:
Medication:_________________________________
Gauze:_____________________________________
Adhesive:___________________________________
Wound Status Continuum
Plot the total score on the Wound Status Continuum by putting an “X” on the line and the date
beneath the line.
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APPENDIX E
PAUL-PIEPER ITCHING QUESTIONNAIRE
Code Number _____
1. Rate the amount of itching you have on your body
0
None

1

2

3

4

5

6

7

8

9 10
Unbearable itching

** If no itching reported, do not proceed.**
a.
b.
c.
d.
e.
f.
g.
h.

2. If you have itching, where on your body does it bother you (check all that apply)?
Head ____
Arms ____
Hands ____
Chest ____
Back ____
Legs ____
Feet ____
Other (Please specify where) __________________

i.
j.
k.
l.
m.
n.
o.
p.
q.
r.
s.
t.
u.
v.
w.
x.
y.
z.
aa.
bb.
cc.
dd.

3. What relieves or decreases your body itching? Check all that apply
Cold pack/ice ____
Heating pad_____
Taking a cool shower or tub bath _____
Hot/warm water ______
Epsom’s salt ____
Air blowing on the area ____
Vasoline or petrolatum ____
Lotion (Calamine) ______
Steroid ointment (Cortaid)____
Steroid cream (Synalar)_____
Antibiotic ointment ____
Menthol ointment (Vicks) _____
Menthol lotion (Sarna) _____
Antihistamine pill (Benadryl or Atarax) ____
Antihistamine cream (Benadryl)____
Capsaicin (Zostrix) ______
Local anesthetic (Lidoderm)_____
Watching TV _____
Listening to music _____
Rubbing the area ______
Scratching the area _______
Other (please specify) _____________________
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4. What makes your itching worse?
ee.
Heat _____
ff.
Cold ______
gg.
Eating certain foods _____
hh.
Worry _____
ii.
Other ______
5. Do you have a wound?
a.___ Yes
b. ___ No
If yes, “Please answer questions about itching and wounds.”
6. Where on your body is the wound?
jj.
Head ____
kk.
Arms ____
ll.
Hands ____
mm.
Chest ____
nn.
Back ____
oo.
Legs ____
pp.
Feet ____
qq.
Other (Please specify where) __________________
7. How long have you had the wound?
___days
___weeks
___months

___years

8. Have procedures been done to your wound?
a.__yes
b.__no
If “yes,” please list date and type of last procedure:
Date of last procedure:______
Type of last procedure:______
9. Does your wound itch?
a.___yes
b.___no
If “no,” do not proceed. The questioning is complete.
10. Rate the amount of itching you have on your wound
0 1 2 3 4 5 6 7 8 9 10
None
Unbearable itching
11. Rate the amount of itching you have on your skin around the wound
None

0 1 2 3 4 5 6 7 8 9 10
Unbearable itching
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a.
b.
c.
d.
e.

12. How long has your wound been bothered with itching?
1 week or less _____
1-6 months _____
7 -11 months ______
1-5 years _______
Greater than 5 years _______

a.
b.
c.
d.

13. When does your wound itch the most (select one)?
Morning ______
Afternoon ______
Evening ______
During sleep _____

14. What treatment(s) do you use for wound itching (check all that apply)?
a. Cold pack/ice ____
b. Heating pad_____
c. Taking a cool shower or tub bath _____
d. Hot/warm water ______
e. Epsom’s salt ____
f. Air blowing on the area ____
g. Vaseline or petrolatum ____
h. Lotion (Calamine) ______
rr. Steroid ointment (Cortaid)____
ss. Steroid cream (Synalar)_____
tt. Antibiotic ointment ____
uu. Menthol ointment (Vicks) _____
vv. Menthol lotion (Sarna) _____
ww. Antihistamine pill (Benadryl or Atarax) ____
xx. Antihistamine cream (Benedryl)____
yy. Capsaicin (Zostrix) ______
zz. Local anesthetic (Lidoderm)_____
aaa. Watching TV _____
bbb.Listening to music _____
ccc. Rubbing the area ______
ddd.Scratching the area _______
eee. Other (please specify) _____________________

a.
b.
c.
d.
e.

15. What makes your wound itch worse?
Heat _____
Cold ______
Eating certain foods _____
Worry _____
Other ______
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APPENDIX F
CHARACTERISTICS OF ITCH QUESTIONNAIRE
Section 1: Personal Information
Sex: Male
Female
Country:___________________
Family Status: Never married Married

Date of Birth/ (Age):____________
Divorced

Separated

Widowed

Which of the following best describes your primary racial or ethnic identification? (Check
all that apply)
__ Black (African, African American)
__Hispanic (Mexican, Puerto Rican, Cuban, Latin American)
__Native American (American Indian, Alaska Native)
__White (Caucasian)
__Asian, Oriental
__Native Hawaiian + Other Pacific Islander
__Other (Specify) ____________________
Which is the highest level of education that you have completed? (Check the appropriate
box)
__No formal education
__Some grade school
__Completed grade school
__Some high school
__Completed high school
__Some college
__Completed 2- or 4-year college degree
__Some graduate education
__A graduate professional degree
Are you presently: (Check the appropriate box)
__Employed, full time
__Employed, part time
__Unemployed
__Retired
__Student
__Full-time homemaker
How would you classify your overall health status?
__Poor
__Fair
__Good
__Excellent
Medical history:
Dermatologic diagnosis(es):__________________________________________
Medical diagnosis(es):_______________________________________________
__________________________________________________________________
__________________________________________________________________
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Current Medication(s):______________________________________________
__________________________________________________________________
Section 2: Itch History
Q1. Do you currently suffer from itch?
__Yes
__No
Q2. Have you suffered from itch within the past year? __Yes
__No
Q3. How many months and/or years have you suffered from itch?________________
Q4. How often does itch occur?
__Greater than 10 episodes per day
__5 to 10 episodes per day
__2 to 4 episodes per day
__1 episode per day
__2 to 6 episodes per week
__1 episode per week
__1 episode per month
Q5. What symptoms occur along with itch? (Check all that apply)
__Pain within area of itch
__Sweating
__Heat sensation
__Cold sensation
Other(s)_____________________________________________________
Q6. Location of itch:
Anterior Posterior
__Face
Hand
_______
_______
__Scalp
Forearm
_______
_______
__Neck
Arm
_______
_______
__Shoulder
Thigh
_______
_______
__Armpit
Shin
_______
_______
__Chest
Foot
_______
_______
__Abdomen
Other
_______
_______
__Back
__Buttocks
__Groin
Section 3: Characteristics of Itch
To what extent do the descriptions below match your itch?
0 = Not at all
1 = To a minimal extent
2 = To a mild extent
3 = To a moderate extent
4 = To a great extent
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0

1

2

3

4

Pulsating
Throbbing
Prickling

1

2

3

4

0

1

2

3

4

Sharp
Tingling
comes in
waves
Hot
Unbearable
Annoying
bothersome
mosquito-bite
like
Unpleasant
Awful

Hurting
Tickling
Painful
Stinging
Warm
Burning
Penetratin
g
Inflaming
Disgusting
Tiresome

Bothering
unmanageable
my only
desire: no itch
Stubborn

Tiring
0
restricting
my life
disturbing
my sleep
more when
cold
Acute
more when
warm
pinpricklike
Itching
feels antlike
like
sunburn

0

1

2

3

4
Severe
Pricking
Dreadful
Oppressive
Insistent
uncontrollable
Terrible
Torturing
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When do you feel the itch?
0 1 2 3 4
In the morning
During the day
In the evening
At night
During the Spring
During the
Summer
During the Autumn
During the Winter

If applicable, fill in

Y N

Constantly (all day and
night)
Constantly during the
day
Constantly during the
night
Intermittently
Frequency of attacks
per day
Duration of attacks
Duration of interval
without itch
Association with rash

Please identify the intensity of a typical episode of itch that has occurred within the last two
weeks.
10
9
8
7
6
5
4
3
2
1
Unbearable
None
Please identify the result that scratching has on a typical episode of itch within the last two
weeks.
5
4
3
2
1
0
-1
-2
-3
-4
-5
Highly pleasurable (5)
Neutral (0)
Highly unpleasurable (-5)
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APPENDIX G
RAND-12
1. In general, would you say your health is:
__1 = Excellent
__2 =Very good
__3 = Good
__4 = Fair
__5 =Poor
The following items are about activities you might do during a typical day. Does your health
now limit you in these activities? If so, how much?
2. Moderate activities, such as moving a table, pushing a vacuum cleaner, bowling, or playing
golf
__1 = Yes, limited a lot
__2 =Yes, limited a little
__3 = No, not limited at all
3. Climbing several flights of stairs
__1 = Yes, limited a lot
__2 =Yes, limited a little
__3 = No, not limited at all
During the past four weeks, have you had any of the following problems with your work or other
regular daily activities as a result of your physical health?
4. Accomplished less than you would like
__1 =Yes
__2 = No
5. Were limited in the kind of work or other activities
__1 = Yes
__2 = No
During the past four weeks, have you had any of the following problems with your work or other
regular daily activities as a result of any emotional problems (such as feeling depressed or
anxious)?
6. Accomplished less than you would like
__1 = Yes
__2 = No
7. Didn’t do work or other activities as carefully as usual
__1 = Yes
__2 = No
8. During the past four weeks, how much did pain interfere with your normal work (including
both work outside the home and housework)?
__1 = Not at all
__2 = A little bit
__3 = Moderately
__4 = Quite a bit
__5 = Extremely
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The following questions are about how you feel and how things have been with you during the
past four weeks. For each question, please give the one answer that comes closest to the way
you have been feeling. How much of the time during the past four weeks:
9. Have you felt calm and peaceful?
__1 = All of the time
__2 = Most of the time
__3 = A good bit of the time
__4 = Some of the time
__5 = A little of the time
__6 = None of the time
10. Did you have a lot of energy?
__1 = All of the time
__2 = Most of the time
__3 = A good bit of the time
__4 = Some of the time
__5 = A little of the time
__6 = None of the time
11. Have you felt downhearted and blue?
__1 = All of the time
__2 = Most of the time
__3 = A good bit of the time
__4 = Some of the time
__5 = A little of the time
__6 =None of the time
12. During the past four weeks, how much of the time has your physical health or emotional
problems interfered with your social activities (like visiting with friends, relatives, etc.)?
__1 = All of the time
__2 = Most of the time
__3 = Some of the time
__4 = A little of the time
__5 = None of the time
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APPENDIX H
BRIEF PAIN INVENTORY (SHORT FORM)
1. Throughout our lives, most of us have had pain from time to time (such as minor headaches,
sprains, and toothaches). Have you had pain other than these everyday kinds of pain today?
__Yes
__No
2. On the diagram, shade the areas where you feel pain. Put an “X” on the area that hurts the
most.

3. Please rate your pain by choosing the one number that best describes your pain at its worst in
the last 24 hours.
0
1
2
3
4
5
6
7
8
9
10
No pain
Pain as bad as you can imagine
4. Please rate your pain by choosing the one number that best describes your pain at its least in
the last 24 hours.
0
1
2
3
4
5
6
7
8
9
10
No pain
Pain as bad as you can imagine
5. Please rate your pain by choosing the one number that best describes your pain on the
average.
0
1
2
3
4
5
6
7
8
9
10
No pain
Pain as bad as you can imagine
6. Please rate your pain by choosing the one number that tells how much pain you have right
now.
0
1
2
3
4
5
6
7
8
9
10
No pain
Pain as bad as you can imagine
7. What treatments or medications are you receiving for your pain?

8. In the last 24 hours, how much relief have pain treatments or medications provided? Please
circle the one percentage that most shows how much relief you have received.
0%
10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
No relief
Complete relief
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9. Circle the one number that describes how, during the past 24 hours, pain has interfered
With your:
A. General activity
0
1
2
3
4
5
6
7
8
9
10
Does not
Completely
interfere
interferes
B. Mood
0
1
2
3
4
5
6
7
8
9
10
Does not
Completely
interfere
interferes
C. Walking ability
0
1
2
3
4
5
6
7
8
9
10
Does not
Completely
interfere
interferes
D. Normal work (includes both work outside the home and housework)
0
1
2
3
4
5
6
7
8
9
10
Does not
Completely
interfere
interferes
E. Relations with other people
0
1
2
3
4
5
6
7
8
9
10
Does not
Completely
interfere
interferes
F. Sleep
0
1
2
3
4
5
6
7
8
9
10
Does not
Completely
interfere
interferes
G. Enjoyment of life
0
1
2
3
4
5
6
7
8
9
10
Does not
Completely
interfere
interferes
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APPENDIX I
WOUND ITCH INTERVIEW TOOL
1. Sex:
a.___Male
b.___Female
2. Date of Birth/ (Age):____________
3. Country:___________________
4. Family Status:
a.___Never married
b.___Married
c.___Divorced
d.___Separated
e.___Widowed
5. Which of the following best describes your primary racial or ethnic identification?
(Check all that apply)
a.___ Black (African, African American)
b,___ Hispanic (Mexican, Puerto Rican, Cuban, Latin American)
c.___Native American (American Indian, Alaska Native)
d.___White (Caucasian)
e.___Asian, Oriental
f.___Native Hawaiian + Other Pacific Islander
g.___Other (Specify) ____________________
6. Which is the highest level of education that you have completed? (Check the
appropriate box)
a.___No formal education
b.___Some grade school
c.___Completed grade school
d.___Some high school
e.___Completed high school
f.___ Some college
g.___Completed 2- or 4-year college degree
h.___Some graduate education
i.____A graduate professional degree
7. Are you presently: (Check the appropriate box)
a.___Employed, full time
b.___Employed, part time
c.___Unemployed
d.___Retired
e.___Student
f.___Full-time homemaker
8. How would you classify your overall health status?
a.___Poor
b.___Fair
c.___Good
d.___Excellent
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RAND-12
9. In general, would you say your health is:
___1 = Excellent
___2 =Very good
___3 = Good
___4 = Fair
___5 =Poor
The following items are about activities you might do during a typical day. Does your health
now limit you in these activities? If so, how much?
10. Moderate activities, such as moving a table, pushing a vacuum cleaner, bowling, or playing
golf
__1 = Yes, limited a lot
__2 =Yes, limited a little
__3 = No, not limited at all
11. Climbing several flights of stairs
__1 = Yes, limited a lot
__2 =Yes, limited a little
__3 = No, not limited at all
During the past four weeks, have you had any of the following problems with your work or other
regular daily activities as a result of your physical health?
12. Accomplished less than you would like
__1 =Yes
__2 = No
13. Were limited in the kind of work or other activities
__1 = Yes
__2 = No
During the past four weeks, have you had any of the following problems with your work or other
regular daily activities as a result of any emotional problems (such as feeling depressed or
anxious)?
14. Accomplished less than you would like
__1 = Yes
__2 = No
15. Didn’t do work or other activities as carefully as usual
__1 = Yes
__2 = No
16. During the past four weeks, how much did pain interfere with your normal work (including
both work outside the home and housework)?
__1 = Not at all
__2 = A little bit
__3 = Moderately
__4 = Quite a bit
__5 = Extremely
The following questions are about how you feel and how things have been with you during the
past four weeks. For each question, please give the one answer that comes closest to the way
you have been feeling. How much of the time during the past four weeks:
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17. Have you felt calm and peaceful?
__1 = All of the time
__2 = Most of the time
__3 = A good bit of the time
__4 = Some of the time
__5 = A little of the time
__6 = None of the time
18. Did you have a lot of energy?
__1 = All of the time
__2 = Most of the time
__3 = A good bit of the time
__4 = Some of the time
__5 = A little of the time
__6 = None of the time
19. Have you felt downhearted and blue?
__1 = All of the time
__2 = Most of the time
__3 = A good bit of the time
__4 = Some of the time
__5 = A little of the time
__6 =None of the time
20. During the past four weeks, how much of the time has your physical health or emotional
problems interfered with your social activities (like visiting with friends, relatives, etc.)?
__1 = All of the time
__2 = Most of the time
__3 = Some of the time
__4 = A little of the time
__5 = None of the time
Pain History
Brief Pain Inventory (Short Form)
21. Most of us have had pain from time to time (such as minor headaches, sprains, and
toothaches). Have you had pain other than these everyday kinds of pain today?
__Yes
__No
22. On the diagram, shade the areas where you feel pain. Put an “X” on the area that hurts the
most.
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23. Please rate your pain by choosing the one number that best describes your pain at its worst
in the last 24 hours.
0
1
2
3
4
5
6
7
8
9
10
No pain
Pain as bad as you
can imagine
24. Please rate your pain by choosing the one number that best describes your pain at its least in
the last 24 hours.
0
1
2
3
4
5
6
7
8
9
10
No pain
Pain as bad as you
can imagine
25. Please rate your pain by choosing the one number that best describes your pain on the
average.
0
1
2
3
4
5
6
7
8
9
10
No pain
Pain as bad as you
can imagine
26. Please rate your pain by choosing the one number that tells how much pain you have right
now.
0
1
2
3
4
5
6
7
8
9
10
No pain
Pain as bad as you
can imagine
27. What treatments or medications are you receiving for your pain?

28. In the last 24 hours, how much relief have pain treatments or medications provided? Please
circle the one percentage that most shows how much relief you have received.
0%
10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
No relief
Complete relief
29. Circle the one number that describes how, during the past 24 hours, pain has interfered:
With your:
A. General activity
0
1
2
3
4
5
6
7
8
9
10
Does not
Completely
interfere
interferes
B. Mood
0
1
2
3
4
5
6
7
8
9
Does not
Interfere
C. Walking ability
0
1
2
3
4
5
6
7
8
9
Does not
Interfere
D. Normal work (includes both work outside the home and housework)
0
1
2
3
4
5
6
7
8
9
Does not

10
Completely
interferes
10
Completely
interferes
10
Completely
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Interfere
E. Relations with other people
0
1
2
3
4
Does not
Interfere
F. Sleep
0
1
2
3
4
Does not
Interfere
G. Enjoyment of life
0
1
2
3
4
Does not
Interfere

interferes
5

6

7

8

9

10
Completely
interferes

5

6

7

8

9

10
Completely
interferes

5

6

7

8

9

10
Completely
interferes

30. Do you have pain related to your wound?
a.____Yes, around the wound
b.____Yes, in the wound
c.____No
If “no,” proceed to # 35 (questions about itch).
31. Rate the amount of pain you have on your wound
0 1 2 3 4 5 6 7 8 9 10
None
Unbearable pain
32. Rate the amount of pain you have on the skin around the wound
0 1 2 3 4 5 6 7 8 9 10
None
Unbearable pain

Characteristics of Wound Pain
33. To what extent do the descriptions below match your pain?
0 = Not at all
1 = To a minimal extent
2 = To a mild extent
3 = To a moderate extent
4 = To a great extent
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0

1

2

3

4

Pulsating
Throbbing
Prickling

1

2

3

4

0

1

2

3

4

Sharp
Tingling
comes in
waves
Hot
unbearable
Annoying
bothersome
mosquito-bite
like
unpleasant
Awful

Hurting
Tickling
Painful
Stinging
Warm
Burning
Penetratin
g
Inflaming
Disgusting
Tiresome

Bothering
unmanageable
my only
desire: no itch
Stubborn

Tiring
0
restricting
my life
disturbing
my sleep
more when
cold
Acute
more when
warm
pinpricklike
Itching
feels antlike
like
sunburn

0

1

2

3

4
Severe
Pricking
Dreadful
Oppressive
Insistent
uncontrollable
Terrible
Torturing
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34. When do you feel the pain?
0 1 2 3 4

If applicable, fill in

In the morning

Y N

Constantly (all day and
night)
Constantly during the
day
Constantly during the
night
Intermittently
Frequency of attacks
per day
Duration of attacks

During the day
In the evening
At night
During the Spring
During the
Summer
During the Autumn

Duration of interval
without itch
Association with rash

During the Winter
35. Do you have a wound?
a.___Yes
b.___ No

If yes, please answer questions about itching and wounds.
36. Location of wound:
a.__Face
b.__Scalp
c.__Neck
d.__Shoulder
e.__Armpit
f.__Chest
g.__Abdomen
h.__Back
i.__Buttocks
j.__Groin

Hand
Forearm
Arm
Thigh
Shin
Foot
Other

Anterior Posterior
k._______
l. _______
m._______ n. _______
o._______
p. _______
q._______
r. _______
s._______
t._______
u._______
v._______
_______

37. Is the itch in the area of a wound?
a.__Yes, around the wound

b.__Yes, in the wound

c.__No
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38. Rate the amount of itching you have on your wound
0 1 2 3 4 5 6 7 8 9 10
None
Unbearable itching
39. Rate the amount of itching you have on your skin around the wound
0 1 2 3 4 5 6 7 8 9 10
None
Unbearable itching
40. How long has your wound been bothered with itching?
a. 1 week or less _____
b. 1-6 months _____
c. 7 -11 months ______
d. 1-5 years _______
e. Greater than 5 years _______
41. When does your wound itch the most (select one)?
a. Morning ______
b. Afternoon ______
c. Evening ______
d. During sleep _____
42. What treatment(s) do you use for wound itching (check all that apply)?
a. Cold pack/ice ____
b. Heating pad_____
c. Taking a cool shower or tub bath _____
d. Hot/warm water ______
e. Epsom’s salt ____
f. Air blowing on the area ____
g. Vaseline or petrolatum ____
h. Lotion (Calamine) ______
i. Steroid ointment (Cortaid)____
j. Steroid cream (Synalar)_____
k. Antibiotic ointment ____
l. Menthol ointment (Vicks) _____
m. Menthol lotion (Sarna) _____
n. Antihistamine pill (Benadryl or Atarax) ____
o. Antihistamine cream (Benedryl)____
p. Capsaicin (Zostrix) ______
q. Local anesthetic (Lidoderm)_____
r. Watching TV _____
s. Listening to music _____
t. Rubbing the area ______
u. Scratching the area _______
v. Other (please specify) _____________________
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43. What makes your wound itch worse?
a. Heat _____
b. Cold ______
c. Eating certain foods _____
d. Worry _____
e. Other ______

Characteristics of Wound Itch
44. To what extent do the descriptions below match your wound itch? (These descriptors are
the same as previously used to describe pain.)
0 = Not at all
1 = To a minimal extent
2 = To a mild extent
3 = To a moderate extent
4 = To a great extent
0
1
2
3
4
0
1
2
3
4
Pulsating
Sharp
Throbbing
Tingling
Prickling
comes in
waves
Hurting
Hot
Tickling
unbearable
Painful
Annoying
Stinging
bothersome
Warm
mosquito-bite
like
Burning
unpleasant
Penetratin
Awful
g
Inflaming
Bothering
Disgusting
unmanageable
Tiresome
my only
desire: no itch
Tiring
Stubborn
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0

1

2

3

4

restricting
my life
disturbing
my sleep
more when
cold
Acute
more when
warm
pinpricklike
Itching
feels antlike
like
sunburn
45. When do you feel the itch?
0 1 2 3 4
In the morning
During the day
In the evening
At night
During the Spring
During the
Summer
During the Autumn
During the Winter

0

1

2

3

4

Severe
Pricking
Dreadful
Oppressive
Insistent
uncontrollable
Terrible
Torturing

If applicable, fill in

Y N

Constantly (all day and
night)
Constantly during the
day
Constantly during the
night
Intermittently
Frequency of attacks
per day
Duration of attacks
Duration of interval
without itch
Association with rash

46. Please identify the intensity of a typical episode of itch that has occurred within the last
two weeks.
10
9
8
7
6
5
4
3
2
1
Unbearable
None
47. Please identify the result that scratching has on a typical episode of itch within the last two
weeks.
5
4
3
2
1
0
-1
-2
-3
-4
-5
Highly pleasurable (5)
Neutral (0)
Highly unpleasurable (-5)
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Itch History
You have been asked about itch related to your wound. Please answer the following questions
about any other itch you experience.
48. Do you currently suffer from itch?
a.__Yes
b.__No
49. Have you suffered from itch within the past year?
a.__Yes
b.__No
50. How many months and/or years have you suffered from itch?________________
51. How often does itch occur?
a.___Greater than 10 episodes per day
b.___5 to 10 episodes per day
c.___2 to 4 episodes per day
d.___1 episode per day
e.___2 to 6 episodes per week
f.___1 episode per week
g.___1 episode per month
52. What symptoms occur along with itch? (Check all that apply)
a.___Pain within area of itch
b.___Sweating
c.___Heat sensation
d.___Cold sensation
Other(s)_____________________________________________________
53. Location of itch:
a.__Face
b.__Scalp
c.__Neck
d.__Shoulder
e.__Armpit
f.__Chest
g.__Abdomen
h.__Back
i.__Buttocks
j.__Groin

Hand
Forearm
Arm
Thigh
Shin
Foot
Other

Anterior Posterior
k._______
l. _______
m._______ n. _______
o._______
p. _______
q._______
r. _______
s._______
t._______
u._______
v._______
_______

54. Rate the amount of itching you have on your body
0 1

2

3 4
None

5

6

7

8

9 10
Unbearable itching
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55. What relieves or decreases your body itching? Check all that apply
a. Cold pack/ice ____
b. Heating pad_____
c. Taking a cool shower or tub bath _____
d. Hot/warm water ______
e. Epsom’s salt ____
f. Air blowing on the area ____
g. Vaseline or petrolatum ____
h. Lotion (Calamine) ______
i. Steroid ointment (Cortaid)____
j. Steroid cream (Synalar)_____
k. Antibiotic ointment ____
l. Menthol ointment (Vicks) _____
m. Menthol lotion (Sarna) _____
n. Antihistamine pill (Benadryl or Atarax) ____
o. Antihistamine cream (Benedryl)____
p. Capsaicin (Zostrix) ______
q. Local anesthetic (Lidoderm)_____
r. Watching TV _____
s. Listening to music _____
t. Rubbing the area ______
u. Scratching the area _______
v. Other (please specify) _____________________
56.What makes your itching worse?
a. Heat _____
b. Cold ______
c. Eating certain foods _____
d. Worry _____
e. Other ______
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APPENDIX J
MEDICAL RECORD DATA COLLECTION TOOL
[This information obtained from medical record]
Wound diagnosis/ type:_____________________________________________
Dermatologic diagnosis(es):__________________________________________
Medical diagnosis(es):_______________________________________________
__________________________________________________________________
__________________________________________________________________
Current Medication(s):______________________________________________
__________________________________________________________________
__________________________________________________________________
Allergies:_________________________________________________________
__________________________________________________________________
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APPENDIX K
APPROVAL FROM BEAUMONT COMMISSION OF NURSING SCHOLARSHIP AND
RESEARCH

November 9, 2010

Ms. Julia Paul
3601 W. 13 Mile
Royal Oak, MI 48073
Re: Itch Occurring with Chronic Wounds
Dear Julia:
The above mentioned project was reviewed by the Commission of Nursing Scholarship and
Research and is approved to be conducted as specified in the application at Beaumont HospitalRoyal Oak.

Sincerely,

Cathy Campbell, MSN, APRN, BC
Director Nursing Scholarship, Quality & Research

127

APPENDIX L – BEAUMONT HIC APPROVAL
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APPENDIX M - WAYNE STATE UNIVERSITY HIC APPROVAL
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Background: Itch is an irritation of the skin which can be as disturbing as pain. It is a familiar
phenomenon yet remains poorly understood. Itch associated with wounds is recognized clinically, but is
not well described in the literature related to chronic wounds commonly encountered in wound care
practice. Chronic wounds include vascular, neuropathic, traumatic, and pressure-related wounds as well
as wounds of mixed etiology. Chronic wounds mostly affect those persons over sixty years of age, so the
percentage of persons with chronic wounds is likely to increase with the aging of society. Because of the
itch-scratch cycle, wounds can be perpetuated by scratching in response to itch. Frequency of wound
itch, characteristics of wounds that itch, measures used by persons with chronic wounds to manage wound
itch, and impact that itch has on quality of life for persons with chronic wounds is not known. Nurses are
in a unique position for assessment and management of wound itch. The Theory of Wound Itch derived
from Levine’s Principles of Conservation provided a theoretical framework for this nursing study.
Purpose: To examine the phenomenon of itch associated with chronic wounds as found in wound care
practice. Research questions were: (a) What is the frequency, timing, duration and intensity of itch
related to chronic wounds? (b) What are the characteristics of wounds that itch? (c) What treatments do
participants use to manage wound itch? (d) How does wound itch affect quality of life for these
participants? (e) What is the relationship between wound itch and pain? Methods: The study design was
observational, descriptive. 200 participants will be recruited from hospital-affiliated wound care centers.
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Participants were interviewed with structured interview tools, and wounds were assessed according
components of the Bates-Jensen Wound Assessment Tool. Data were analyzed to answer the research
questions using descriptive and parametric statistics. Results: Participants were 21 to 98 years (M =
66.82; SD = 14.02); men (56%) and women; primarily white (85%). One fourth of participants (56 of
199) reported wound-related itch. Compared to wounds without itch, wounds that itched were generally
larger, t(72.71) = -2.38, p = .02, d = .50, 95% CI[-21.88, -1.92], had more tissue edema, t(88.38) = -2.20,
2

p = .03, d = .37, 95% CI[-0.93, -0.05], and more granulation tissue in the wound base, X (4, N = 198) =

8.06, p = .09. Rubbing (14.5%) and scratching (12.0%) were described as well as lotion to the area of
wound itch (10%). No effect on quality of life was found. Wound-related pain and wound-related itch
were positively correlated (r = .17, p = .02). Conclusion: Wound itch was described by one fourth of
persons with chronic wounds. Wound itch was present with larger wounds, with more tissue edema, and
with more granulation tissue in the wound base. While no effect on quality of life was found, participants
were able to distinguish wound itch from pain and described it as annoying and bothersome. Pain and
wound itch were positively correlated. Implications: This study advanced nursing science by providing
an understanding of itch with chronic wounds, so that itch might be assessed and treated to promote
healing and improve quality of life for persons with chronic wounds.
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